You searched for subject:(cancer)
.
Showing records 1 – 30 of
31525 total matches.
◁ [1] [2] [3] [4] [5] … [1051] ▶
1.
Fergione, Sarah J.
Engineering 3D Human Cortical Microtissues Harboring
Patient-Derived Glioblastomas.
Degree: Department of Molecular Pharmacology, Physiology and
Biotechnology, 2018, Brown University
URL: https://repository.library.brown.edu/studio/item/bdr:792897/
► Human glioblastomas develop within the brain parenchyma in which there is continuous interaction of glioma cells with axon fibers, glial cells and endothelial cells. This…
(more)
▼ Human glioblastomas develop within the brain
parenchyma in which there is continuous interaction of glioma cells
with axon fibers, glial cells and endothelial cells. This cellular
interplay cannot be accounted for with the current monolayer in
vitro models. Moreover, the development of new therapies against
glioblastoma has often failed due to toxicities that were not
identified through in vitro studies and animal testing. To mitigate
some of these limitations, we have developed an all human ex vivo
3D glioblastoma model. ReNcell CX cells, an immortalized human
neural progenitor cell line, were used as the base of the 3D model.
ReNcell CX cells were seeded into micromolds to form self-assembled
spheroids and subsequently induced to differentiate. After 46 days
of differentiation, spheroids were fixed, embedded, and
cryosectioned for immunostaining to confirm assembly of polarized
cortical microtissues. N-cadherin is essential for maintaining the
polarized architecture of neuroepithelial cells in the cerebral
cortex through the formation of adherent junctions. We show that
our human cortical spheroids express N-cadherin in a polarized
pattern close to the apical surface of the spheroids. To verify the
presence of neocortical progenitors we stained with Pax6, while the
presence of mature cortical neurons was verified with TuJ and Bf1
staining. To investigate the invasion of glioma cells into the
human cortical spheroids, a confrontation assay between cortical
and glioma spheroids was implemented. Finally, spheroids were fixed
and stained using combinations of glioma cell and cortical neuron
specific markers. The proposed model aims to mitigate some of the
limitations in current in vitro and in vivo approaches. Our 3D
human brain microtissues will be used to gain a more in-depth
understanding of the origins of brain
cancer, including the
migration and invasion of glioblastoma into the brain parenchyma,
and serve as drug development platform to test novel
cancer
therapeutics.
Advisors/Committee Members: Morgan, Jeff (Advisor), Ip, Blanche (Reader), Tapinos, Nikos (Advisor).
Subjects/Keywords: Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Fergione, S. J. (2018). Engineering 3D Human Cortical Microtissues Harboring
Patient-Derived Glioblastomas. (Thesis). Brown University. Retrieved from https://repository.library.brown.edu/studio/item/bdr:792897/
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Fergione, Sarah J. “Engineering 3D Human Cortical Microtissues Harboring
Patient-Derived Glioblastomas.” 2018. Thesis, Brown University. Accessed April 21, 2021.
https://repository.library.brown.edu/studio/item/bdr:792897/.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Fergione, Sarah J. “Engineering 3D Human Cortical Microtissues Harboring
Patient-Derived Glioblastomas.” 2018. Web. 21 Apr 2021.
Vancouver:
Fergione SJ. Engineering 3D Human Cortical Microtissues Harboring
Patient-Derived Glioblastomas. [Internet] [Thesis]. Brown University; 2018. [cited 2021 Apr 21].
Available from: https://repository.library.brown.edu/studio/item/bdr:792897/.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Fergione SJ. Engineering 3D Human Cortical Microtissues Harboring
Patient-Derived Glioblastomas. [Thesis]. Brown University; 2018. Available from: https://repository.library.brown.edu/studio/item/bdr:792897/
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
2.
Smith, Tyler.
The Role of the Transcription Factor SREBP2 in Glioblastoma
Cancer Cells.
Degree: Biomedical Engineering, 2017, Brown University
URL: https://repository.library.brown.edu/studio/item/bdr:733518/
► Abstract of The Role of the Transcription Factor SREBP2 in Glioblastoma Cancer Cells, by Tyler Smith, ScM., Brown University, May 2018. Cholesterol is a vital…
(more)
▼ Abstract of The Role of the Transcription Factor
SREBP2 in Glioblastoma
Cancer Cells, by Tyler Smith, ScM., Brown
University, May 2018. Cholesterol is a vital molecule in cellular
function, ranging from overall membrane stability to cell
signaling. Intracellular cholesterol homeostasis is carefully
regulated. The cholesterol pathway is regulated by a master
transcription factor SREBP2, whose targets are responsible for both
cholesterol synthesis and cholesterol uptake. In this study, we
found that a U87 SREBF2-KD cell line is unable to compensate under
normal or low cholesterol environment, and that lowered expression
of SREBP2 sensitized cells to statins. Activation of the
transcription factor LXR, which is responsible for cholesterol
efflux, did not display synergistic killing of GBM
cancer cells in
combination with lower expression of SREBP2. Knock down lines were
unable to compensate in neurosphere conditions; however, a
phenotype was not fully assessed in that model. This SREBF2-KD line
could provide great insight into GBM treatments, and furthermore
the technology could be applied to GBM patient derived
lines.
Advisors/Committee Members: Brodsky, Alexander (Advisor), Wong, Ian (Reader), Webb, Ashley (Reader).
Subjects/Keywords: Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Smith, T. (2017). The Role of the Transcription Factor SREBP2 in Glioblastoma
Cancer Cells. (Thesis). Brown University. Retrieved from https://repository.library.brown.edu/studio/item/bdr:733518/
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Smith, Tyler. “The Role of the Transcription Factor SREBP2 in Glioblastoma
Cancer Cells.” 2017. Thesis, Brown University. Accessed April 21, 2021.
https://repository.library.brown.edu/studio/item/bdr:733518/.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Smith, Tyler. “The Role of the Transcription Factor SREBP2 in Glioblastoma
Cancer Cells.” 2017. Web. 21 Apr 2021.
Vancouver:
Smith T. The Role of the Transcription Factor SREBP2 in Glioblastoma
Cancer Cells. [Internet] [Thesis]. Brown University; 2017. [cited 2021 Apr 21].
Available from: https://repository.library.brown.edu/studio/item/bdr:733518/.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Smith T. The Role of the Transcription Factor SREBP2 in Glioblastoma
Cancer Cells. [Thesis]. Brown University; 2017. Available from: https://repository.library.brown.edu/studio/item/bdr:733518/
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
3.
Graham, Elizabeth Grace.
Polymer Dynamic Organic Theranostic Spheres for Photothermal Therapy and Fluorescent Imaging of Cancer.
Degree: 2015, Wake Forest University
URL: http://hdl.handle.net/10339/57185
► Nanoparticle mediated photothermal ablation of cancer is a promising technique that utilizes light energy to destroy cancer cells. Specifically, nanoparticles that absorb in the near…
(more)
▼ Nanoparticle mediated photothermal ablation of cancer is a promising technique that utilizes light energy to destroy cancer cells. Specifically, nanoparticles that absorb in the near infrared (NIR) region of light, 700 - 900 nm, are optimal because these wavelengths are an absorption minimum for water, hemoglobin, and deoxygenated hemoglobin. As these wavelengths are where tissues are most transparent, NIR photothermal therapies allow for efficacious localized hyperthermia. Our lab has recently utilized poly[4,4-bis(2-ethylhexyl)-cyclopenta[2,1-b;3,4-b']dithiophene-2,6-diyl-alt−2,1,3-benzoselenadiazole-4,7-diyl] (PCPDTBSe), a conjugated polymer, to form nanoparticles capable of generating effective photothermal ablation when stimulated by NIR light.
Subjects/Keywords: cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Graham, E. G. (2015). Polymer Dynamic Organic Theranostic Spheres for Photothermal Therapy and Fluorescent Imaging of Cancer. (Thesis). Wake Forest University. Retrieved from http://hdl.handle.net/10339/57185
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Graham, Elizabeth Grace. “Polymer Dynamic Organic Theranostic Spheres for Photothermal Therapy and Fluorescent Imaging of Cancer.” 2015. Thesis, Wake Forest University. Accessed April 21, 2021.
http://hdl.handle.net/10339/57185.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Graham, Elizabeth Grace. “Polymer Dynamic Organic Theranostic Spheres for Photothermal Therapy and Fluorescent Imaging of Cancer.” 2015. Web. 21 Apr 2021.
Vancouver:
Graham EG. Polymer Dynamic Organic Theranostic Spheres for Photothermal Therapy and Fluorescent Imaging of Cancer. [Internet] [Thesis]. Wake Forest University; 2015. [cited 2021 Apr 21].
Available from: http://hdl.handle.net/10339/57185.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Graham EG. Polymer Dynamic Organic Theranostic Spheres for Photothermal Therapy and Fluorescent Imaging of Cancer. [Thesis]. Wake Forest University; 2015. Available from: http://hdl.handle.net/10339/57185
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Debrecen
4.
Gurpinar, Melisa.
Different Types of Cancer
.
Degree: DE – TEK – Természettudományi és Technológiai Kar – Biológiai és Ökológiai Intézet, 2012, University of Debrecen
URL: http://hdl.handle.net/2437/128533
Cancer is a leading cause of death worldwide and according to WHO (World Health Organisation) 7.6 million people worldwide died from cancer in 2008, and 30% of cancer could be prevented.
Advisors/Committee Members: Bánfalvi, Gáspár (advisor).
Subjects/Keywords: Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Gurpinar, M. (2012). Different Types of Cancer
. (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/128533
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Gurpinar, Melisa. “Different Types of Cancer
.” 2012. Thesis, University of Debrecen. Accessed April 21, 2021.
http://hdl.handle.net/2437/128533.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Gurpinar, Melisa. “Different Types of Cancer
.” 2012. Web. 21 Apr 2021.
Vancouver:
Gurpinar M. Different Types of Cancer
. [Internet] [Thesis]. University of Debrecen; 2012. [cited 2021 Apr 21].
Available from: http://hdl.handle.net/2437/128533.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Gurpinar M. Different Types of Cancer
. [Thesis]. University of Debrecen; 2012. Available from: http://hdl.handle.net/2437/128533
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Melbourne
5.
Cheung, Vanessa.
The role of PTHrP and Apo2L/TRAIL in breast cancer.
Degree: 2012, University of Melbourne
URL: http://hdl.handle.net/11343/37379
► Parathyroid hormone-related protein (PTHrP) is a key component in breast tumour biology. PTHrP is one of the main factors implicated in breast cancer osteolysis. Clinical…
(more)
▼ Parathyroid hormone-related protein (PTHrP) is a key component in breast tumour biology. PTHrP is one of the main factors implicated in breast cancer osteolysis. Clinical studies have determined that PTHrP expression by primary breast cancers was an independent predictor of improved prognosis. Furthermore, PTHrP has been described to cause tumour cell death both in vitro and in vivo. A promising new anti-cancer agent is Apo2L/TRAIL due to its ability to selectively induce apoptosis in cancer cells whilst sparing most normal cells. However, some cancer cells are resistant to Apo2L/TRAIL-induced apoptosis thus limiting its therapeutic efficacy. Since both PTHrP and Apo2L/TRAIL has profound effects on breast cancer, the actions of these two factors were assessed.
The effect of PTHrP on gene expression in breast cancer cells was studied. PTHrP was overexpressed in two breast cancer cell lines; MCF-7 and MDA-MB-231, and knocked down in MDA-MB-231, and analysed gene expression by microarray analysis. Cytochrome p450 1B1 (CYP1B1) was identified as a potential factor differentially altered by PTHrP in breast cancer cells.
To assess the relationship of PTHrP with factors in the cell death pathways, PTHrP overexpressing breast cancer cells were treated with Apo2L/TRAIL. PTHrP overexpression increased MDA-MB-231 cells sensitivity to Apo2L/TRAIL-induced apoptosis. Interestingly, PTHrP sensitised MCF-7 cells to Apo2L/TRAIL-induced apoptosis. Apo2L/TRAIL-induced apoptosis in PTHrP overexpressing cells through the activation of caspase-10 resulting in caspase-9 activation and induction of apoptosis through the effector caspases, caspase-6 and -7. Studies with PTHrP peptides 1-34, 38-94, 67-86, 107-111, 106-139, 120-139 and 107-139 on MDA-MB-231 cells showed no effect on Apo2L/TRAIL-induced apoptosis, indicating that PTHrP’s action were unlikely to result from extracellular receptor signalling. PTHrP did not alter mRNA expression of Apo2L/TRAIL receptors; TRAIL-R1, TRAIL-R2, TRAIL-R3, TRAIL-R4 and OPG, however increased cell surface expression the death receptors TRAIL-R1 and TRAILR2 was observed. Antagonistic antibodies against the death receptors demonstrated that Apo2L/TRAIL preferentially bound to TRAIL-R2 to signal apoptosis.
To identify potential genes involved in Apo2L/TRAIL resistance and/or sensitivity gene microarray experiments were performed comparing two breast cancer cell lines with differential sensitivities to Apo2L/TRAIL. CYP1B1 and CARD10 were identified to be differentially expressed. CARD10 was regulated by Apo2L/TRAIL in MDA-MB-231 cells, however there was no associated with PTHrP. CYP1B1 mRNA expression was decreased in PTHrP overexpressing cells. CYP1B1 mRNA expression was further down regulated by Apo2L/TRAIL in PTHrP overexpressing breast cancer cells. Overexpression studies of CYP1B1 in PTHrP overexpressing cells did not affect Apo2L/TRAIL-induced apoptosis, indicating that…
Subjects/Keywords: Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Cheung, V. (2012). The role of PTHrP and Apo2L/TRAIL in breast cancer. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/37379
Chicago Manual of Style (16th Edition):
Cheung, Vanessa. “The role of PTHrP and Apo2L/TRAIL in breast cancer.” 2012. Doctoral Dissertation, University of Melbourne. Accessed April 21, 2021.
http://hdl.handle.net/11343/37379.
MLA Handbook (7th Edition):
Cheung, Vanessa. “The role of PTHrP and Apo2L/TRAIL in breast cancer.” 2012. Web. 21 Apr 2021.
Vancouver:
Cheung V. The role of PTHrP and Apo2L/TRAIL in breast cancer. [Internet] [Doctoral dissertation]. University of Melbourne; 2012. [cited 2021 Apr 21].
Available from: http://hdl.handle.net/11343/37379.
Council of Science Editors:
Cheung V. The role of PTHrP and Apo2L/TRAIL in breast cancer. [Doctoral Dissertation]. University of Melbourne; 2012. Available from: http://hdl.handle.net/11343/37379
6.
Samsonova, Anastasiia.
Structural and functional insights into YB-1 and Lin28 interplay in mRNA regulation : Étude de la base structurale de l'interaction entre YB-1 et Lin28 et de ses conséquences fonctionnelles dans la régulation de la traduction.
Degree: Docteur es, Sciences de la vie et de la santé, 2020, université Paris-Saclay
URL: http://www.theses.fr/2020UPASL037
► La régulation de l'ARNm dans les cellules humaines est l'un des mécanismes essentiels permettant aux cellules de s'adapter à un nouvel environnement et de répondre…
(more)
▼ La régulation de l'ARNm dans les cellules humaines est l'un des mécanismes essentiels permettant aux cellules de s'adapter à un nouvel environnement et de répondre aux signaux entrants. En effet, il est bien plus efficace pour une cellule de réguler l'homéostasie protéique au niveau de la traduction des ARNm plutôt qu'en jouant sur la transcription ou les mécanismes de dégradation des protéines. Dans les mécanismes de régulation de la traduction de l'ARNm, les protéines de liaison à l'ARN (RBP) jouent un rôle clé.Au cours de ce travail de recherche, nous avons démontré que Lin28, une RBP humaine avec un domaine de choc froid peut interagir avec l'ARNm en coopération avec YB1, une protéine très abondante contenant aussi un domaine de choc froid, essentielle dans la constitution des mRNPs. L'interaction entre ces deux protéines est basée sur leur haute similitude de structure, et permet potentiellement à Lin28a de réguler la traduction nombreux mRNPs en utilisant YB-1 comme «badge d'entrée» au mRNP.Pour étudier l'interaction entre Lin28 et YB-1, différentes méthodes de biologie structurale et cellulaire ont été utilisées. D'abord, l'oligomérisation des domaines de choc froid de Lin28 et YB-1 en présence d'ARNm a été démontrée in vitro, et les résidus d'acides aminés impliqués dans ce processus ont été mis en évidence par spectroscopie RMN. Ensuite, la colocalisation dans le cytoplasme de Lin28 et YB-1 a été démontrée dans un contexte cellulaire. Finalement, nous avons révélé les conséquences fonctionnelles de cette interaction, par exemple dans le cadre de la prolifération et de la différenciation cellulaires. Ces résultats éclairent un nouveau rôle de Lin28 dans le développement et l'adaptation des cellules cancéreuses à leur environnement.
The mRNA regulation in human cells is one of the key mechanisms allowing the cells to adapt to a new environment and to respond to incoming signals. In terms of protein synthesis, the regulation of mRNA translation is a preferable process for cells compared to a more rigid mechanism of transcription or degradation. The RNA-binding proteins (RBPs) play a key role in the mRNA translation regulation.In the present work, we made an effort to demonstrate that a human RBP containing a cold shock domain, Lin28a, can act in cooperation with another cold shock protein YB-1, a core protein of mRNPs. The interplay between two cold shock proteins is based on their high structure similarity, that potentially gives Lin28 an opportunity to regulate the mRNA target translation in a general way using YB 1 as an “entry badge” to the mRNP.To demonstrate the interplay between Lin28 and YB 1, several methods of structural and cellular biology were used in the present study. The oligomerization of Lin28-CSD and YB-1-CSD upon RNA binding was shown in vitro, and the amino acid residues responsible for that were highlighted by NMR spectroscopy. Then, the colocalization of Lin28 and YB-1 was demonstrated in cell cytoplasm. Also, the protein interplay was shown to have functional consequences, e.g. for…
Advisors/Committee Members: Hamon, Loïc (thesis director), Pastre, David (thesis director).
Subjects/Keywords: Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Samsonova, A. (2020). Structural and functional insights into YB-1 and Lin28 interplay in mRNA regulation : Étude de la base structurale de l'interaction entre YB-1 et Lin28 et de ses conséquences fonctionnelles dans la régulation de la traduction. (Doctoral Dissertation). université Paris-Saclay. Retrieved from http://www.theses.fr/2020UPASL037
Chicago Manual of Style (16th Edition):
Samsonova, Anastasiia. “Structural and functional insights into YB-1 and Lin28 interplay in mRNA regulation : Étude de la base structurale de l'interaction entre YB-1 et Lin28 et de ses conséquences fonctionnelles dans la régulation de la traduction.” 2020. Doctoral Dissertation, université Paris-Saclay. Accessed April 21, 2021.
http://www.theses.fr/2020UPASL037.
MLA Handbook (7th Edition):
Samsonova, Anastasiia. “Structural and functional insights into YB-1 and Lin28 interplay in mRNA regulation : Étude de la base structurale de l'interaction entre YB-1 et Lin28 et de ses conséquences fonctionnelles dans la régulation de la traduction.” 2020. Web. 21 Apr 2021.
Vancouver:
Samsonova A. Structural and functional insights into YB-1 and Lin28 interplay in mRNA regulation : Étude de la base structurale de l'interaction entre YB-1 et Lin28 et de ses conséquences fonctionnelles dans la régulation de la traduction. [Internet] [Doctoral dissertation]. université Paris-Saclay; 2020. [cited 2021 Apr 21].
Available from: http://www.theses.fr/2020UPASL037.
Council of Science Editors:
Samsonova A. Structural and functional insights into YB-1 and Lin28 interplay in mRNA regulation : Étude de la base structurale de l'interaction entre YB-1 et Lin28 et de ses conséquences fonctionnelles dans la régulation de la traduction. [Doctoral Dissertation]. université Paris-Saclay; 2020. Available from: http://www.theses.fr/2020UPASL037

Oregon State University
7.
Le, Uyen Minh.
Improving the uptake and retention of gadolinium in tumors for potential gadolinium-neutron capture therapy: Integration of gemcitabine or localized irradiation into dsRNA therapy significantly enhanced the resultant anti-tumor activity.
Degree: PhD, Pharmacy, 2008, Oregon State University
URL: http://hdl.handle.net/1957/9442
► Cancer is one of the leading causes of death in the U.S., and new approaches to control cancer are constantly sought. This dissertation is comprised…
(more)
▼ Cancer is one of the leading causes of death in the U.S., and new approaches to
control
cancer are constantly sought. This dissertation is comprised of two parts: (i)
improving the uptake and retention of gadolinium in tumors for potential gadoliniumneutron
capture therapy (Gd-NCT) and (ii) integration of gemcitabine or localized
irradiation into dsRNA therapy significantly enhanced the resultant anti-tumor
activity.
One of the key factors for a successful Gd-NCT is to deliver and maintain a
sufficient amount of Gd in tumor tissues (50-200 μg of Gd/g of wet tumor) during
neutron irradiation, which has proven to be challenging to achieve. A gadolinium-encapsulated
liposome (Gd-liposome) formulation was designed to address this need.
The formulation was prepared by complexing diethylenetriaminepentaacetic acid (Gd-
DTPA) with poly-L-lysine and then encapsulating the Gd-DTPA complexes intopegylated liposomes. The Gd-liposome formulation delivered as high as 159 μg of
pure Gd per g of wet tumor tissue into model tumors in mice. A liposome-in-thermosensitive
gel system that significantly extended the retention of the Gd in model
tumors in mice was also designed. These Gd delivery systems may be used to deliver
Gd into solid tumors for NCT and tumor imaging.
Despite of the potent tumoricidal activity of polyinosine-cytosine (e.g. poly(I:C)),
a synthetic dsRNA, in culture, its in vivo anti-tumor activity has proven to be limited.
Gemcitabine, a chemotherapy agent, or localized x-ray radiation was successfully
integrated into poly(I:C) therapy to improve the resultant anti-tumor activity in murine
tumor models. Combining gemcitabine with poly(I:C) synergistically inhibited the
growth of model tumors in mice and also generated a strong and durable tumorspecific
immune response. Alternatively, integrating localized x-ray radiation into
poly(I:C) therapy significantly delayed the tumor growth, but the combined activity
was synergistic only in mice with highly immunogenic tumors, indicating that the T
cell-mediated immunity was responsible for the synergy. The type I interferons (IFN-
α/β) induced by poly(I:C) played a critical role in the resultant anti-tumor activity.
These combination therapies may represent a promising approach to improve the
clinical outcomes of poly(I:C) therapy.
Advisors/Committee Members: CUI, ZHENGRONG (advisor), CHRISTENSEN, JOHN MARK (committee member).
Subjects/Keywords: cancer; Cancer – Radiotherapy
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Le, U. M. (2008). Improving the uptake and retention of gadolinium in tumors for potential gadolinium-neutron capture therapy: Integration of gemcitabine or localized irradiation into dsRNA therapy significantly enhanced the resultant anti-tumor activity. (Doctoral Dissertation). Oregon State University. Retrieved from http://hdl.handle.net/1957/9442
Chicago Manual of Style (16th Edition):
Le, Uyen Minh. “Improving the uptake and retention of gadolinium in tumors for potential gadolinium-neutron capture therapy: Integration of gemcitabine or localized irradiation into dsRNA therapy significantly enhanced the resultant anti-tumor activity.” 2008. Doctoral Dissertation, Oregon State University. Accessed April 21, 2021.
http://hdl.handle.net/1957/9442.
MLA Handbook (7th Edition):
Le, Uyen Minh. “Improving the uptake and retention of gadolinium in tumors for potential gadolinium-neutron capture therapy: Integration of gemcitabine or localized irradiation into dsRNA therapy significantly enhanced the resultant anti-tumor activity.” 2008. Web. 21 Apr 2021.
Vancouver:
Le UM. Improving the uptake and retention of gadolinium in tumors for potential gadolinium-neutron capture therapy: Integration of gemcitabine or localized irradiation into dsRNA therapy significantly enhanced the resultant anti-tumor activity. [Internet] [Doctoral dissertation]. Oregon State University; 2008. [cited 2021 Apr 21].
Available from: http://hdl.handle.net/1957/9442.
Council of Science Editors:
Le UM. Improving the uptake and retention of gadolinium in tumors for potential gadolinium-neutron capture therapy: Integration of gemcitabine or localized irradiation into dsRNA therapy significantly enhanced the resultant anti-tumor activity. [Doctoral Dissertation]. Oregon State University; 2008. Available from: http://hdl.handle.net/1957/9442
8.
Funsani, Peter.
Morbidity and mortality trend analysis of cervical cancer in Zambia for the period 2007 to 2014: a case of Cancer Diseases Hospital.
Degree: 2016, University of Zimbabwe
URL: http://dspace.unza.zm/handle/123456789/4885
► In 2014 alone, over 3 million women aged ≥15 years were at risk of being diagnosed with cervical cancer in Zambia. Our study aimed at…
(more)
▼ In 2014 alone, over 3 million women aged ≥15 years were at risk of being diagnosed with
cervical cancer in Zambia. Our study aimed at examining trends and factors associated with
cervical cancer morbidity and mortality, among cases presented at the Cancer Diseases
Hospital (CDH), in Lusaka, Zambia. A retrospective case-study was conducted to review
cervical cancer morbidity and mortality between 2007 and 2014 at Cancer Diseases Hospital
(CDH). Eligible cervical cancer cases and deaths recorded from Zambian patients ≥15 years
were reviewed using a set criterion. Descriptive statistics were generated for all the variables
and further analyses were done using Chi-square, Ordinary least-squares regression and Coxhazard
regression in SPSS ver20. Cervical cancer cases were highest in 2012, compared to
other years; a unit increase in years, resulted in 8.1 increase in numbers of cases. Conversely,
a unit increase in years, resulted in a 3.7 reduction in cervical cancer deaths at CDH. Mean
age at diagnosis was 49.9 and 51.5 years at death. High cases were reported among married
women of child-bearing age, living in urban areas. Those ≥56 years were 1.1 times more
likely to die of cervical cancer than those younger. Risk of death was also influenced by
advanced stages of cancer and HIV status. The general overall mean months of survival to
death was 58.4 months. Months of survival were statistically affected by factors such as age,
staging, radiotherapy as type of treatment, and of HIV positive status. This study established an
increasing trend of cervical cancer cases and reducing mortality over 2007-2014. Late
diagnosis and HIV positive status increases the case fatality risks among the patients at CDH.
We recommend to setting up deliberate cervical cancer screening services especially among
HIV positive women.
Subjects/Keywords: Cervical Cancer; Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Funsani, P. (2016). Morbidity and mortality trend analysis of cervical cancer in Zambia for the period 2007 to 2014: a case of Cancer Diseases Hospital. (Thesis). University of Zimbabwe. Retrieved from http://dspace.unza.zm/handle/123456789/4885
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Funsani, Peter. “Morbidity and mortality trend analysis of cervical cancer in Zambia for the period 2007 to 2014: a case of Cancer Diseases Hospital.” 2016. Thesis, University of Zimbabwe. Accessed April 21, 2021.
http://dspace.unza.zm/handle/123456789/4885.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Funsani, Peter. “Morbidity and mortality trend analysis of cervical cancer in Zambia for the period 2007 to 2014: a case of Cancer Diseases Hospital.” 2016. Web. 21 Apr 2021.
Vancouver:
Funsani P. Morbidity and mortality trend analysis of cervical cancer in Zambia for the period 2007 to 2014: a case of Cancer Diseases Hospital. [Internet] [Thesis]. University of Zimbabwe; 2016. [cited 2021 Apr 21].
Available from: http://dspace.unza.zm/handle/123456789/4885.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Funsani P. Morbidity and mortality trend analysis of cervical cancer in Zambia for the period 2007 to 2014: a case of Cancer Diseases Hospital. [Thesis]. University of Zimbabwe; 2016. Available from: http://dspace.unza.zm/handle/123456789/4885
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of New Mexico
9.
Smith, Randi L.
Tumor Promoting Properties of Field Cancerized Fibroblasts in Cell Culture.
Degree: Biomedical Sciences Graduate Program, 2015, University of New Mexico
URL: https://digitalrepository.unm.edu/biom_etds/93
► Our recent studies have shown that Tumor Adjacent Histologically Normal (TAHN) breast tissue demonstrates many of the characteristics of breast tumors. For example, through immunohistochemical…
(more)
▼ Our recent studies have shown that Tumor Adjacent Histologically Normal (TAHN) breast tissue demonstrates many of the characteristics of breast tumors. For example, through immunohistochemical staining with markers such as alpha smooth muscle actin and TGF-β, we have shown the accumulation of myofibroblasts in TAHN tissues 1 cm from the tumor margin (TAHN-1). Additionally, TAHN-1 epithelia stain positive for epithelial to mesenchymal transition (EMT) associated proteins, such as transforming growth factor beta and alpha smooth muscle actin. The purpose of this study was to determine if TAHN-1 fibroblasts retained myofibroblast characteristics and if they could induce EMT in primary culture. We isolated primary cells from tissue specimens taken 1cm and 5cm from a breast tumor (TAHN-1, TAHN-5). Primary fibroblasts were stained positive for myofibroblast markers, and contracted a collagen gel, demonstrating that these cells retain their myofibroblast characteristics. Primary fibroblast conditioned culture media was also able to induce EMT markers and migration normal epithelial breast cells.
Advisors/Committee Members: Trujillo, Kristina, Garver, William Sherman, Hartley, Rebecca, Trujillo, Kristina.
Subjects/Keywords: Cancer; Breast Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Smith, R. L. (2015). Tumor Promoting Properties of Field Cancerized Fibroblasts in Cell Culture. (Masters Thesis). University of New Mexico. Retrieved from https://digitalrepository.unm.edu/biom_etds/93
Chicago Manual of Style (16th Edition):
Smith, Randi L. “Tumor Promoting Properties of Field Cancerized Fibroblasts in Cell Culture.” 2015. Masters Thesis, University of New Mexico. Accessed April 21, 2021.
https://digitalrepository.unm.edu/biom_etds/93.
MLA Handbook (7th Edition):
Smith, Randi L. “Tumor Promoting Properties of Field Cancerized Fibroblasts in Cell Culture.” 2015. Web. 21 Apr 2021.
Vancouver:
Smith RL. Tumor Promoting Properties of Field Cancerized Fibroblasts in Cell Culture. [Internet] [Masters thesis]. University of New Mexico; 2015. [cited 2021 Apr 21].
Available from: https://digitalrepository.unm.edu/biom_etds/93.
Council of Science Editors:
Smith RL. Tumor Promoting Properties of Field Cancerized Fibroblasts in Cell Culture. [Masters Thesis]. University of New Mexico; 2015. Available from: https://digitalrepository.unm.edu/biom_etds/93

Universiteit Utrecht
10.
Yilmaz, V.
Cancer Immunotherapy.
Degree: 2012, Universiteit Utrecht
URL: http://dspace.library.uu.nl:8080/handle/1874/253742
► Cancer is the leading cause of death in economically developed countries and the conventional anti-cancer therapies fail to meet the criteria of an ideal, safe…
(more)
▼ Cancer is the leading cause of death in economically developed countries and the conventional anti-
cancer therapies fail to meet the criteria of an ideal, safe and highly effective therapy especially against the metastatic
cancer types.
Cancer immunotherapy is an up-coming anti-
cancer therapy that uses the patient’s own immune system to target and kill the
cancer cells. There are several different strategies and approaches to the
cancer immunotherapy in respect to the diverse hallmarks of
cancer. While some of these immunotherapeutic agents are approved and made their way into practice, some needs further development and assessment in trials. This study aims to review the already accepted and newly developing immunotherapies against
cancer and also to shed light on the issues associated with
cancer immunotherapy that determine its failures, successes and future in clinical studies and medical practice.
Advisors/Committee Members: Zaiss, D., Sijts, A..
Subjects/Keywords: Cancer; Immunotherapy; cancer immunology; cancer treatment
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Yilmaz, V. (2012). Cancer Immunotherapy. (Masters Thesis). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/253742
Chicago Manual of Style (16th Edition):
Yilmaz, V. “Cancer Immunotherapy.” 2012. Masters Thesis, Universiteit Utrecht. Accessed April 21, 2021.
http://dspace.library.uu.nl:8080/handle/1874/253742.
MLA Handbook (7th Edition):
Yilmaz, V. “Cancer Immunotherapy.” 2012. Web. 21 Apr 2021.
Vancouver:
Yilmaz V. Cancer Immunotherapy. [Internet] [Masters thesis]. Universiteit Utrecht; 2012. [cited 2021 Apr 21].
Available from: http://dspace.library.uu.nl:8080/handle/1874/253742.
Council of Science Editors:
Yilmaz V. Cancer Immunotherapy. [Masters Thesis]. Universiteit Utrecht; 2012. Available from: http://dspace.library.uu.nl:8080/handle/1874/253742

University of Tasmania
11.
Breaden, Katrina.
Cancer and beyond : the question of survivorship.
Degree: 1995, University of Tasmania
URL: https://eprints.utas.edu.au/18855/1/whole_BreadenKatrina1995_thesis.pdf
► In Australia, as in many other countries in the Western world, the five year survival rate for persons diagnosed with cancer is now approaching 50…
(more)
▼ In Australia, as in many other countries in the Western world, the five year
survival rate for persons diagnosed with cancer is now approaching 50 per
cent. Although there is a growing population of cancer survivors, little is
known about what surviving entails. Nurses usually do not feature in
survivors' lives, for survivors are mostly lost to our experience as they
leave the treatment merry-go-round. Traditionally, a survivor has been
defined as one who has been disease-free for a period of five years or
more. However, this definition in terms of linear time, does not reveal the
experience nor the process of survival. This process commences at the
point of diagnosis of cancer and continues for life.
The aim of this thesis is to present a phenomenological exploration of the
meanings and experiences of surviving cancer. Using a method of
hermeneutic phenomenology (as described by van Manen 1990), the study
draws on the stories of six women, who by their definition are surviving
cancer. Through research conversations, the women describe what this
experience has been like. A discussion of themes has been structured
according to the everyday experiences of living in a body and living in
time. The women describe a survival process that includes: feeling whole
again; the body as the house of suspicion; the future in question; changes
in time; lucky to be alive; and sharing the journey. The thrust of the work
is to deepen nurses' understandings of survivorship.
Subjects/Keywords: Cancer; Cancer; Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Breaden, K. (1995). Cancer and beyond : the question of survivorship. (Thesis). University of Tasmania. Retrieved from https://eprints.utas.edu.au/18855/1/whole_BreadenKatrina1995_thesis.pdf
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Breaden, Katrina. “Cancer and beyond : the question of survivorship.” 1995. Thesis, University of Tasmania. Accessed April 21, 2021.
https://eprints.utas.edu.au/18855/1/whole_BreadenKatrina1995_thesis.pdf.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Breaden, Katrina. “Cancer and beyond : the question of survivorship.” 1995. Web. 21 Apr 2021.
Vancouver:
Breaden K. Cancer and beyond : the question of survivorship. [Internet] [Thesis]. University of Tasmania; 1995. [cited 2021 Apr 21].
Available from: https://eprints.utas.edu.au/18855/1/whole_BreadenKatrina1995_thesis.pdf.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Breaden K. Cancer and beyond : the question of survivorship. [Thesis]. University of Tasmania; 1995. Available from: https://eprints.utas.edu.au/18855/1/whole_BreadenKatrina1995_thesis.pdf
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Tasmania
12.
Jones, Catherine Cheryl.
Two worlds in one : the lived experiences of seven people treated with autologous bone marrow/peripheral blood stem cell transplant.
Degree: 1996, University of Tasmania
URL: https://eprints.utas.edu.au/20373/1/whole_JonesCatherineCheryl1997_thesis.pdf
► Autologous bone marrow/peripheral blood stem cell transplant is one of the recent treatments to offer hope of a cure or prolonged remission for certain types…
(more)
▼ Autologous bone marrow/peripheral blood stem cell transplant is one of the
recent treatments to offer hope of a cure or prolonged remission for certain
types of cancer. Current literature predominantly has either a biomedical
focus or deals with long term survivorship issues. The ways in which this
treatment option is perceived by survivors is important in providing nurses
with a deeper insight and understanding with which to inform nursing
care.
Utilising a phenomenological hermeneutic methodology seven people who
have survived this treatment, participated in sharing their stories in
individual audio-taped interviews. Themes which emerged from the text
include: changing concepts of self; the significance of relationships; being
different from the past; and temporality.
Subjects/Keywords: Cancer; Cancer; Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Jones, C. C. (1996). Two worlds in one : the lived experiences of seven people treated with autologous bone marrow/peripheral blood stem cell transplant. (Thesis). University of Tasmania. Retrieved from https://eprints.utas.edu.au/20373/1/whole_JonesCatherineCheryl1997_thesis.pdf
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Jones, Catherine Cheryl. “Two worlds in one : the lived experiences of seven people treated with autologous bone marrow/peripheral blood stem cell transplant.” 1996. Thesis, University of Tasmania. Accessed April 21, 2021.
https://eprints.utas.edu.au/20373/1/whole_JonesCatherineCheryl1997_thesis.pdf.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Jones, Catherine Cheryl. “Two worlds in one : the lived experiences of seven people treated with autologous bone marrow/peripheral blood stem cell transplant.” 1996. Web. 21 Apr 2021.
Vancouver:
Jones CC. Two worlds in one : the lived experiences of seven people treated with autologous bone marrow/peripheral blood stem cell transplant. [Internet] [Thesis]. University of Tasmania; 1996. [cited 2021 Apr 21].
Available from: https://eprints.utas.edu.au/20373/1/whole_JonesCatherineCheryl1997_thesis.pdf.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Jones CC. Two worlds in one : the lived experiences of seven people treated with autologous bone marrow/peripheral blood stem cell transplant. [Thesis]. University of Tasmania; 1996. Available from: https://eprints.utas.edu.au/20373/1/whole_JonesCatherineCheryl1997_thesis.pdf
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Université de Grenoble
13.
Sambourg, Laure.
Décrypter les données omiques : importance du contrôle qualité. Application au cancer de l'ovaire : Decipher omics data, on the importance of quality control.
Degree: Docteur es, Modèles, méthodes et algorithmes en biologie, santé et environnement, 2013, Université de Grenoble
URL: http://www.theses.fr/2013GRENS027
► Décrypter les données omiques : importance du contrôle qualité. Application au cancer de l’ovaire Au cours des dix dernières années, la taille et la complexité…
(more)
▼ Décrypter les données omiques : importance du contrôle qualité. Application au cancer de l’ovaire Au cours des dix dernières années, la taille et la complexité des données biologiques ont littéralement explosé, et une attention particulière doit être portée au contrôle qualité. En effet, certaines données omiques (données génomiques et post-génomiques obtenues à haut débit) sont très incomplètes et/ou contiennent de nombreux biais et erreurs qu’il est facile de confondre avec de l’information biologiquement intéressante. Dans cette thèse, nous montrons que les interactions protéine-protéine issues de curation de la littérature et les interactions identifiées à haut débit sont beaucoup plus corrélées que ce qui est communément admis. Nous examinons l’interactome de la levure d’un point de vue original, en prenant en compte le degré d’étude des protéines par la communauté scientifique et nos résultats indiquent que cette corrélation s’estompe lorsqu’on se restreint aux protéines très étudiées. Ces observations nous permettent de proposer une méthode simple et fiable pour estimer la taille d’un interactome. Notre méthode conduit à une estimation d’au moins 37 600 interactions physiques directes chez S. cerevisiae, et montre que les évaluations précédentes sont trop faibles. Par ailleurs, nous étudions des données de séquençage nouvelle génération de l’ADN. Par une analyse des biais existant entre les short-reads alignés sur un brin ou sur l’autre du génome, nous mettons en évidence de nombreuses erreurs systématiques. De plus, nous observons de multiples positions présentant entre 20 et 40% de short-reads portant l’allèle variant : celles-ci ne peuvent pas être génotypées correctement. Nous proposons une méthode fiable pour appeler les génotypes à partir des données NGS qui permet de s’affranchir de ses difficultés. Enfin, nous appliquons cette méthode sur des données massives de séquençage d’exome de cellules saines et tumorales de 520 patientes atteintes du cancer de l’ovaire, produites par le consortium TCGA. Nous détectons en moyenne 30 632 variants germinaux par patiente. Parmi ces variants, nous identifions ceux les plus enclins à conférer un risque accru de développer la maladie : nous nous restreignons notamment aux variants induisant une perte de fonction de la protéine encodée et significativement plus présents chez les patientes que dans la population générale. Cela conduit à 44 SNVs par patiente en moyenne, répartis sur 334 gènes dans l’ensemble de la cohorte. Parmi ces 334 gènes, 42 ont été reportés comme impliqués dans la cancerogénèse, confirmant que la liste de candidats identifiés est fortement enrichie en gènes de susceptibilité au cancer de l’ovaire. En particulier, nos travaux confirment le rôle de suppresseur de tumeur de la protéine MAP3K8, très récemment proposée comme jouant un rôle clé dans d’autres cancers.
Deciphering omics data : on the importance of quality control. Application to ovarian cancer. Over the past 10 years, the size and complexity of biological data have exploded, and quality…
Advisors/Committee Members: Thierry-Mieg, Nicolas (thesis director).
Subjects/Keywords: NGS; Interactomique; Cancer; Cancer; Interactomic; Cancer; 610
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Sambourg, L. (2013). Décrypter les données omiques : importance du contrôle qualité. Application au cancer de l'ovaire : Decipher omics data, on the importance of quality control. (Doctoral Dissertation). Université de Grenoble. Retrieved from http://www.theses.fr/2013GRENS027
Chicago Manual of Style (16th Edition):
Sambourg, Laure. “Décrypter les données omiques : importance du contrôle qualité. Application au cancer de l'ovaire : Decipher omics data, on the importance of quality control.” 2013. Doctoral Dissertation, Université de Grenoble. Accessed April 21, 2021.
http://www.theses.fr/2013GRENS027.
MLA Handbook (7th Edition):
Sambourg, Laure. “Décrypter les données omiques : importance du contrôle qualité. Application au cancer de l'ovaire : Decipher omics data, on the importance of quality control.” 2013. Web. 21 Apr 2021.
Vancouver:
Sambourg L. Décrypter les données omiques : importance du contrôle qualité. Application au cancer de l'ovaire : Decipher omics data, on the importance of quality control. [Internet] [Doctoral dissertation]. Université de Grenoble; 2013. [cited 2021 Apr 21].
Available from: http://www.theses.fr/2013GRENS027.
Council of Science Editors:
Sambourg L. Décrypter les données omiques : importance du contrôle qualité. Application au cancer de l'ovaire : Decipher omics data, on the importance of quality control. [Doctoral Dissertation]. Université de Grenoble; 2013. Available from: http://www.theses.fr/2013GRENS027

Cornell University
14.
Sullivan, Kelly.
Studies Of The Molecular Mechanisms Underlying Cancer Stem Cells And The Transformed Metabolic Phenotype.
Degree: PhD, Biochemistry, 2015, Cornell University
URL: http://hdl.handle.net/1813/41119
► Intense research throughout recent decades has significantly expanded our knowledge of the complexities that make cancer a highly diverse and therapeutically challenging disease. Recently, cancer…
(more)
▼ Intense research throughout recent decades has significantly expanded our knowledge of the complexities that make
cancer a highly diverse and therapeutically challenging disease. Recently,
cancer stem cells (CSCs) and de-regulated cellular metabolism have become appreciated for their crucial roles in the development, growth, and therapy resistance of tumors, and are now being pursued as therapeutic targets for the treatment of
cancer. To better understand how these oncogenic events contribute to tumor malignancy, I carried out a mechanistic analysis of the CSC marker aldehyde dehydrogenase 1A3 (ALDH1A3) and the GTP-binding protein/crosslinking enzyme tissue transglutaminase (tTG), two proteins suspected to have key roles in tumor initiation and the development of the malignant state, in glioma stem cells (GSCs). Additionally, I examined the contributions of two isoforms of glutaminase (GLS), given the critical role of elevated glutamine metabolism in maintaining the transformed state. In delineating the role of ALDH1A3 in GSCs, I discovered that it is an important regulator of gene expression through the production of retinoic acid (RA). Specifically, I demonstrated that the expression of tTG is induced downstream of ALDH1A3 via RA in highly aggressive GSCs. Furthermore, targeting tTG results in a dramatic reduction in the self-renewal of these cells, suggesting that it may be a viable therapeutic target in ALDH1A3 + GSCs. Finally, I showed that combination therapies including a tTG inhibitor and radiation or chemotherapy are cytotoxic, indicating that tTG inhibitors enhance the effects of standard glioma therapies. Work described in this thesis has also been directed toward understanding the roles of different splice variants of the metabolic enzyme GLS in
cancer cell growth. An important question in the field has concerned whether the two known GLS splice variants, glutaminase C (GAC) and kidney-type glutaminase (KGA), have redundant or opposing functions. This becomes especially relevant when considering the importance of targeting one or both of these enzymes when designing strategies to inhibit the metabolic reprogramming of
cancer cells. Here, I show that although KGA is expressed at low levels in
cancer cells relative to GAC, these isoforms are functionally redundant in their abilities to support the transformed metabolic phenotype.
Advisors/Committee Members: Cerione,Richard A (chair), Emr,Scott David (committee member), Linder,Maurine E. (committee member).
Subjects/Keywords: Cancer stem cells; Cancer metabolism; Cancer therapies
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Sullivan, K. (2015). Studies Of The Molecular Mechanisms Underlying Cancer Stem Cells And The Transformed Metabolic Phenotype. (Doctoral Dissertation). Cornell University. Retrieved from http://hdl.handle.net/1813/41119
Chicago Manual of Style (16th Edition):
Sullivan, Kelly. “Studies Of The Molecular Mechanisms Underlying Cancer Stem Cells And The Transformed Metabolic Phenotype.” 2015. Doctoral Dissertation, Cornell University. Accessed April 21, 2021.
http://hdl.handle.net/1813/41119.
MLA Handbook (7th Edition):
Sullivan, Kelly. “Studies Of The Molecular Mechanisms Underlying Cancer Stem Cells And The Transformed Metabolic Phenotype.” 2015. Web. 21 Apr 2021.
Vancouver:
Sullivan K. Studies Of The Molecular Mechanisms Underlying Cancer Stem Cells And The Transformed Metabolic Phenotype. [Internet] [Doctoral dissertation]. Cornell University; 2015. [cited 2021 Apr 21].
Available from: http://hdl.handle.net/1813/41119.
Council of Science Editors:
Sullivan K. Studies Of The Molecular Mechanisms Underlying Cancer Stem Cells And The Transformed Metabolic Phenotype. [Doctoral Dissertation]. Cornell University; 2015. Available from: http://hdl.handle.net/1813/41119
15.
Elango, J Kalavathy.
Risk profile of oral cancers and strategies to improve
awareness and early detection.
Degree: 2009, Amrita Vishwa Vidyapeetham (University)
URL: http://shodhganga.inflibnet.ac.in/handle/10603/2363
► Fundamentals of implementing any cancer control programs are the understanding of the burden of the disease in the community (incidence trends), risk factor profile and…
(more)
▼ Fundamentals of implementing any cancer control
programs are the understanding of the burden of the disease in the
community (incidence trends), risk factor profile and the awareness
among the public about the cancer and its risk factors. In this
project we attempted to investigate all these three inter related
subjects, which would form the basis to implement a systematic oral
cancer prevention strategy. In addition, we have investigated the
efficacy of a novel oral cancer health education program to improve
awareness of oral cancer in the community. Recent data on the
incidence trends from the low incidence, developed countries
suggest that the head and neck cancers are increasing especially
among young adults. In our study on incidence trends in India of
two large tumor registry data, it was observed that there is an
overall reduction in the incidence of head and neck cancers in
urban and rural populations. However, there was a significant
increase in the incidence of tongue cancers among females. An
attempt was made to compare the Indian data (Mumbai) with the SEER
data from US and it was observed that there was an overall
reduction of head and neck cancers in India, whereas SEER revealed
an increase in the incidence of head and neck cancers among males
and an increase of tongue cancers among females. Among young
adults, an increased incidence of oral cavity and pharynx cancer
was observed among Indian males and tongue cancers among Indian
females. Young Americans showed an overall increase in incidence in
all head and neck cancer subsites except in the laryngeal
cancers.
Annexure p. 160-169
Advisors/Committee Members: Kuriakose, Moni Abraham.
Subjects/Keywords: Oral cancer; Oncology; Cancer prevention; Cancer treatment
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Elango, J. K. (2009). Risk profile of oral cancers and strategies to improve
awareness and early detection. (Thesis). Amrita Vishwa Vidyapeetham (University). Retrieved from http://shodhganga.inflibnet.ac.in/handle/10603/2363
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Elango, J Kalavathy. “Risk profile of oral cancers and strategies to improve
awareness and early detection.” 2009. Thesis, Amrita Vishwa Vidyapeetham (University). Accessed April 21, 2021.
http://shodhganga.inflibnet.ac.in/handle/10603/2363.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Elango, J Kalavathy. “Risk profile of oral cancers and strategies to improve
awareness and early detection.” 2009. Web. 21 Apr 2021.
Vancouver:
Elango JK. Risk profile of oral cancers and strategies to improve
awareness and early detection. [Internet] [Thesis]. Amrita Vishwa Vidyapeetham (University); 2009. [cited 2021 Apr 21].
Available from: http://shodhganga.inflibnet.ac.in/handle/10603/2363.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Elango JK. Risk profile of oral cancers and strategies to improve
awareness and early detection. [Thesis]. Amrita Vishwa Vidyapeetham (University); 2009. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/2363
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

McMaster University
16.
Yan, Judy.
Characterizing prostate cancer stem-like cells and their contribution to prostate cancer tumorigenesis.
Degree: PhD, 2014, McMaster University
URL: http://hdl.handle.net/11375/16285
► On average, 65 Canadian men will be diagnosed with prostate cancer (PC) every day, making it the most common male cancer in Canada. Despite the…
(more)
▼ On average, 65 Canadian men will be diagnosed with prostate cancer (PC) every day, making it the most common male cancer in Canada. Despite the prevalence, the etiology of PC is unknown. Evidence nonetheless supports the role of prostate cancer stem cells (PCSCs) in PC initiation and metastasis. In spite of almost a decade worth of research on PCSCs our knowledge on their biology remains fragmented. By taking advantage of the availability of DU145 cell-derived PCSCs in our laboratory, this thesis research focuses on investigating the unique properties of PCSCs and their function in promoting PC tumorigenesis.
We identified two PCSC-specific proteins, ALDH3A1 and CNTN1. In mouse models of xenograft tumors, ALDH3A1 was expressed at higher levels in PCSC-derived tumors than in DU145 non-PCSC-produced tumors and in lung metastases than local tumors. In clinical settings, elevation of ALDH3A1expression was observed from normal prostate tissues to carcinomas and from local PCs to the paired lymph node metastases. Additionally, ALDH3A1 was clearly detected in bone metastases. Similar to ALDH3A1, CNTN1 expression associates with PC progression and biochemical recurrence following radical prostatectomy. The clear presence of CNTN1 in lymph node and bone metastases was also demonstrated. Furthermore, CNTN1 expression promoted PC metastasis to the lungs and tumor initiation in NOD/SCID mice. Mechanistically, CNTN1 increased AKT activation and reduced E-cadherin expression. Collectively, our research revealed important roles of both PCSC proteins in promoting PC tumorigenesis and progression.
PC develops chemotherapy resistance in which PCSCs play a major role. In supporting this knowledge, we demonstrated that PCSCs are innately more resistant to the chemotherapeutic drugs, etoposide and docetaxel and that this resistance was in part attributable to their enhanced DNA damage response. Taken together, the findings of this thesis advances our knowledge on two specific PCSC markers and their association with prostate cancer progression and metastasis. As well as to the mechanism whereby PCSCs promote resistance to chemotherapeutic drugs.
Thesis
Doctor of Philosophy (PhD)
Advisors/Committee Members: Tang, Damu, Medical Sciences.
Subjects/Keywords: Cancer; Cancer stem cells; Prostate Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Yan, J. (2014). Characterizing prostate cancer stem-like cells and their contribution to prostate cancer tumorigenesis. (Doctoral Dissertation). McMaster University. Retrieved from http://hdl.handle.net/11375/16285
Chicago Manual of Style (16th Edition):
Yan, Judy. “Characterizing prostate cancer stem-like cells and their contribution to prostate cancer tumorigenesis.” 2014. Doctoral Dissertation, McMaster University. Accessed April 21, 2021.
http://hdl.handle.net/11375/16285.
MLA Handbook (7th Edition):
Yan, Judy. “Characterizing prostate cancer stem-like cells and their contribution to prostate cancer tumorigenesis.” 2014. Web. 21 Apr 2021.
Vancouver:
Yan J. Characterizing prostate cancer stem-like cells and their contribution to prostate cancer tumorigenesis. [Internet] [Doctoral dissertation]. McMaster University; 2014. [cited 2021 Apr 21].
Available from: http://hdl.handle.net/11375/16285.
Council of Science Editors:
Yan J. Characterizing prostate cancer stem-like cells and their contribution to prostate cancer tumorigenesis. [Doctoral Dissertation]. McMaster University; 2014. Available from: http://hdl.handle.net/11375/16285
17.
Little, Nicole S.
Investigating the co-evolution of tumor antigens and the anti-tumor immune response.
Degree: Department of Biochemistry and Microbiology, 2017, University of Victoria
URL: https://dspace.library.uvic.ca//handle/1828/8503
► Background: High-grade serous carcinoma (HGSC) can exhibit high intratumoral heterogeneity (ITH). Despite a strong association between tumor-infiltrating lymphocytes (TIL) and survival in HGSC, ITH may…
(more)
▼ Background: High-grade serous carcinoma (HGSC) can exhibit high intratumoral heterogeneity (ITH). Despite a strong association between tumor-infiltrating lymphocytes (TIL) and survival in HGSC, ITH may have profound impacts on the anti-tumor T cell response. Yet, it is unknown how anti-tumor T cell responses contend with ITH over time in HGSC. Previous studies in melanoma and HGSC both showed tumor-reactive T cell clones emerge over time with their cognate tumor-antigens. Therefore, I hypothesized patients would share a common mechanism of T cell evolution to respond to ITH in HGSC. If so, I expect to see similar patterns of tumor recognition between primary and recurrent disease.
Methods: Tumor-associated lymphocytes (TAL) were expanded from primary and recurrent ascites samples using high-dose IL-2 and a rapid-expansion protocol (REP). Following expansion, TAL were assessed for recognition of autologous tumor by IFN-γ ELISPOT and flow cytometry for CD137. CD137+ tumor-reactive TAL were FACS-purified and the tumor-reactive T cell repertoire was profiled by deep sequencing of TCRβ chains (TCRseq). Tumor-reactive TCR clonotypes were compared between primary and recurrent disease to elucidate differences in tumor-reactive populations over time in HGSC.
Results: Patient TAL recognized tumor in two out of three cases. In patient IROC 060, the tumor became more immunogenic between primary and recurrent disease, which may reflect expression of new antigens and/or loss of an immunosuppressive phenotype. In patient IROC 106, the tumor remained immunogenic between primary and recurrent disease, which may reflect maintenance of stable antigen expression and an immune-sensitive phenotype. Patient IROC 034 did not exhibit any tumor-reactivity, suggesting tumor-reactivity is not ubiquitous in HGSC. FACS-purification of CD137+ T cells followed by TCRseq was successfully performed on T cell populations of both high- and low-abundance, suggesting TCRseq can be performed on populations containing very few T cells. TCRseq results that profiled the clonal repertoire of tumor-reactive TAL from primary and recurrent disease in two patients, IROC 060 and IROC 106, showed both patients had evidence of T cell loss and T cell emergence between primary and recurrent disease. Further, IROC 106 had evidence of T cell clones that were maintained between primary and recurrent disease.
Conclusions: Anti-tumor T cell responses from ascites are both diverse between patients and dynamic within a patient, suggesting various mechanisms of T cell evolution to contend with ITH in HGSC. I developed a pipeline for the identification of tumor-reactive TCR sequences without the need for a priori knowledge of specific antigens. Additionally, this pipeline is feasible for very low-abundance samples, such as tumor-reactive T cells.
Significance: This study provides early insights into how TAL contend with ITH in HGSC. Ultimately, these results will inform the design of adoptive T cell therapy for recurrent HGSC.
Advisors/Committee Members: Nelson, Brad H. (supervisor).
Subjects/Keywords: Cancer; Cancer Immunotherapy; Ovarian Cancer; Immunology; Immunotherapy
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Little, N. S. (2017). Investigating the co-evolution of tumor antigens and the anti-tumor immune response. (Masters Thesis). University of Victoria. Retrieved from https://dspace.library.uvic.ca//handle/1828/8503
Chicago Manual of Style (16th Edition):
Little, Nicole S. “Investigating the co-evolution of tumor antigens and the anti-tumor immune response.” 2017. Masters Thesis, University of Victoria. Accessed April 21, 2021.
https://dspace.library.uvic.ca//handle/1828/8503.
MLA Handbook (7th Edition):
Little, Nicole S. “Investigating the co-evolution of tumor antigens and the anti-tumor immune response.” 2017. Web. 21 Apr 2021.
Vancouver:
Little NS. Investigating the co-evolution of tumor antigens and the anti-tumor immune response. [Internet] [Masters thesis]. University of Victoria; 2017. [cited 2021 Apr 21].
Available from: https://dspace.library.uvic.ca//handle/1828/8503.
Council of Science Editors:
Little NS. Investigating the co-evolution of tumor antigens and the anti-tumor immune response. [Masters Thesis]. University of Victoria; 2017. Available from: https://dspace.library.uvic.ca//handle/1828/8503

University of the Western Cape
18.
Fadaka, Adewale Oluwaseun.
MicroRNAs as predictive biomarkers for diagnosis and prognosis of colorectal cancer using in silico approaches
.
Degree: 2019, University of the Western Cape
URL: http://hdl.handle.net/11394/7161
► Colorectal cancer (CRC) is referred to as cancers that arise in the colon or rectum. Rectal cancer is most often defined as cancers originating within…
(more)
▼ Colorectal
cancer (CRC) is referred to as cancers that arise in the colon or rectum. Rectal
cancer
is most often defined as cancers originating within 15 cm from the anal verge. The crude
incidence of CRC in sub-Sahara African populations has been found to be 4.04/100,000 (4.38
for men and 3.69 for women). CRC stage correlates well with survival/cure rates with the
majority of patients diagnosed with CRC presenting with advanced disease and a low
survival/cure rate.
Advisors/Committee Members: Klein, Ashwil (advisor), Pretorius, Ashley (advisor).
Subjects/Keywords: Colorectal cancer;
Cancer biomarkers;
Cancer;
Early detection
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Fadaka, A. O. (2019). MicroRNAs as predictive biomarkers for diagnosis and prognosis of colorectal cancer using in silico approaches
. (Thesis). University of the Western Cape. Retrieved from http://hdl.handle.net/11394/7161
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Fadaka, Adewale Oluwaseun. “MicroRNAs as predictive biomarkers for diagnosis and prognosis of colorectal cancer using in silico approaches
.” 2019. Thesis, University of the Western Cape. Accessed April 21, 2021.
http://hdl.handle.net/11394/7161.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Fadaka, Adewale Oluwaseun. “MicroRNAs as predictive biomarkers for diagnosis and prognosis of colorectal cancer using in silico approaches
.” 2019. Web. 21 Apr 2021.
Vancouver:
Fadaka AO. MicroRNAs as predictive biomarkers for diagnosis and prognosis of colorectal cancer using in silico approaches
. [Internet] [Thesis]. University of the Western Cape; 2019. [cited 2021 Apr 21].
Available from: http://hdl.handle.net/11394/7161.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Fadaka AO. MicroRNAs as predictive biomarkers for diagnosis and prognosis of colorectal cancer using in silico approaches
. [Thesis]. University of the Western Cape; 2019. Available from: http://hdl.handle.net/11394/7161
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Nelson Mandela Metropolitan University
19.
Van Vuuren, Larry Peter.
Identification of membrane biomakers for colorectal cancer using an in-solico and molecular approach.
Degree: Faculty of Science, 2014, Nelson Mandela Metropolitan University
URL: http://hdl.handle.net/10948/47970
► The aim of this study was to identify membrane biomarkers for colorectal cancer using an insilico and molecular approach. Colorectal cancer (CRC) globally accounts for…
(more)
▼ The aim of this study was to identify membrane biomarkers for colorectal cancer using an insilico and molecular approach. Colorectal cancer (CRC) globally accounts for more than half a million deaths. In South Africa alone, approximately one in 97 men is at risk of getting CRC; and for women, it is one in 162. Novel and non-invasive diagnostic tools, such as biomarkers, are needed for early CRC detection. In order to reduce the fatality rate in this disease, Biomarkers are used as indicators of a biological state; and they are measurable in biological media. They can be used to distinguish between a diseased state and a normal state, thus aiding diagnostics, response to specific therapies, and screening for an early diagnosis. A gene list of potential CRC biomarkers was generated by mining two gene databases, namely: Oncomine and Gene Expression Atlas. A total of 44 candidate genes were identified, based on their location on the cell surface, using the Database for Annotation, Visualisation and Integrated Discovery. These 44 genes were then subjected to an in-depth literature mining. The literature search parameters in PubMed, PubMed Central, Google Scholar and Science direct revealed publications showing that 23 genes were validated, while 21 genes were not validated. Nineteen genes were selected for gene validation in human colorectal cancer and healthy tissue of twelve patients. Total RNA was extracted from 12 colorectal cancer and 12 healthy tissue samples. The RNA was then quantified and reverse-transcribed into cDNA for gene expression analysis. The qPCR running conditions were optimized, by running a melting curve, in order to determine the optimum annealing temperatures. Primarily melt curves were run for nineteen of these twenty-one genes. Melt-curve analysis showed that nine genes were poor candidates for further validation studies; and therefore, only ten genes, namely: AGTRAP, ANKRD46, BACE2, CFB, CIAO1, NOMO3, PTDSS1, SLC5A6, TNFRSF12A and ZDHHC9 were validated by qPCR in human resected colorectal carcinoma and the normal tissues of twelve patients. The qPCR results showed that ZDHHC9 and the SLC5A6 genes were the only two statistically significant ones; and they were found to be down-regulated in human colorectal cancer vs healthy tissue samples.
Subjects/Keywords: Cancer – Research; Colon (Anatomy) – Cancer; Rectum – Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Van Vuuren, L. P. (2014). Identification of membrane biomakers for colorectal cancer using an in-solico and molecular approach. (Thesis). Nelson Mandela Metropolitan University. Retrieved from http://hdl.handle.net/10948/47970
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Van Vuuren, Larry Peter. “Identification of membrane biomakers for colorectal cancer using an in-solico and molecular approach.” 2014. Thesis, Nelson Mandela Metropolitan University. Accessed April 21, 2021.
http://hdl.handle.net/10948/47970.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Van Vuuren, Larry Peter. “Identification of membrane biomakers for colorectal cancer using an in-solico and molecular approach.” 2014. Web. 21 Apr 2021.
Vancouver:
Van Vuuren LP. Identification of membrane biomakers for colorectal cancer using an in-solico and molecular approach. [Internet] [Thesis]. Nelson Mandela Metropolitan University; 2014. [cited 2021 Apr 21].
Available from: http://hdl.handle.net/10948/47970.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Van Vuuren LP. Identification of membrane biomakers for colorectal cancer using an in-solico and molecular approach. [Thesis]. Nelson Mandela Metropolitan University; 2014. Available from: http://hdl.handle.net/10948/47970
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Rutgers University
20.
Chen, Jayson Xiao-Chen, 1982-.
Cancer preventive effects of tocopherols in dietary carcinogen-induced colon and prostate carcinogenesis models.
Degree: PhD, Toxicology, 2016, Rutgers University
URL: https://rucore.libraries.rutgers.edu/rutgers-lib/51247/
► Colorectal and prostate cancers are leading causes of morbidity and mortality in the United States and worldwide. While immense progress has been made in reducing…
(more)
▼ Colorectal and prostate cancers are leading causes of morbidity and mortality in the United States and worldwide. While immense progress has been made in reducing incidence and death of these cancers in the past few decades, they remain major public health issues, highlighting the need for better understanding, prevention and intervention of these diseases. One major strategy to address these issues is research into more relevant animal cancer models and potent chemopreventive agents. The purpose of this dissertation research was to characterize a novel colon carcinogenesis model induced by the meat-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), with colitis from Dextran Sodium Sulfate (DSS) and determine the effects of different tocopherol forms of vitamin E on the colon carcinogenesis model as well as a PhIP-induced prostate carcinogenesis model. The rapid induction of PhIP/DSS-induced colon carcinogenesis in the CYP1A-humanized mice was determined to be caused by active Ctnnb1/β-catenin mutations in residual epithelial cells, which when promoted by colitis, developed into precancerous lesion, high-grade dysplasia, and finally adenocarcinoma. These features resembled human colitis-associated colon cancer. In the PhIP/DSS-induced colon carcinogenesis model, dietary supplementation with d-T and g-T, but not a-T, significantly attenuated colon tumor formation and inhibited oxidative and nitrosative stress as well as pro-inflammatory markers. Additional studies indicate the potent inhibitory effects of d-T and g-T was mainly due to protection against early cellular and DNA damage caused by the PhIP carcinogen. In the PhIP-induced prostate carcinogenesis model, dietary supplementation with g-TmT and d-T effectively reduced the formation and severity of mouse PIN lesions as well as p-Akt expression, whereas g-T and a-T were less effective. Further studies suggest the chemopreventive effects of the tocopherols involved the reduction in cellular oxidative and nitrosative stress and inhibition of the PI3K/Akt signaling pathway that regulate cell survival and proliferation. Together, the findings from this research demonstrate the relevance of PhIP dietary carcinogen-induced and DSS colitis-promoted colon carcinogenesis model and the superior cancer preventive activities of d-T and g-T compared to the classic a-T.
Advisors/Committee Members: yang, chung s (chair), Reuhl, Kenneth (internal member), Zarbl, Helmut (internal member), Suh, Nanjoo (internal member), Verzi, Michael (outside member).
Subjects/Keywords: Cancer – Prevention; Colon (Anatomy) – Cancer; Prostate – Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Chen, Jayson Xiao-Chen, 1. (2016). Cancer preventive effects of tocopherols in dietary carcinogen-induced colon and prostate carcinogenesis models. (Doctoral Dissertation). Rutgers University. Retrieved from https://rucore.libraries.rutgers.edu/rutgers-lib/51247/
Chicago Manual of Style (16th Edition):
Chen, Jayson Xiao-Chen, 1982-. “Cancer preventive effects of tocopherols in dietary carcinogen-induced colon and prostate carcinogenesis models.” 2016. Doctoral Dissertation, Rutgers University. Accessed April 21, 2021.
https://rucore.libraries.rutgers.edu/rutgers-lib/51247/.
MLA Handbook (7th Edition):
Chen, Jayson Xiao-Chen, 1982-. “Cancer preventive effects of tocopherols in dietary carcinogen-induced colon and prostate carcinogenesis models.” 2016. Web. 21 Apr 2021.
Vancouver:
Chen, Jayson Xiao-Chen 1. Cancer preventive effects of tocopherols in dietary carcinogen-induced colon and prostate carcinogenesis models. [Internet] [Doctoral dissertation]. Rutgers University; 2016. [cited 2021 Apr 21].
Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/51247/.
Council of Science Editors:
Chen, Jayson Xiao-Chen 1. Cancer preventive effects of tocopherols in dietary carcinogen-induced colon and prostate carcinogenesis models. [Doctoral Dissertation]. Rutgers University; 2016. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/51247/

Rutgers University
21.
Hemler, Jennifer R., 1972-.
Life with, after, or beyond cancer: breast cancer survivorship and the new normal.
Degree: PhD, Sociology, 2015, Rutgers University
URL: https://rucore.libraries.rutgers.edu/rutgers-lib/48509/
► I examine how women “move on,” or are unable to, after a diagnosis of breast cancer. I interviewed 80 survivors of various types and stages…
(more)
▼ I examine how women “move on,” or are unable to, after a diagnosis of breast cancer. I interviewed 80 survivors of various types and stages of breast cancer to explore the relationship between how breast cancer survivors think about cancer and how they manage the daily consequences of this disease, including its effects on identity. My main objective was to examine the cognitive strategies and social practices survivors employ for living with (a history of having had) cancer. Cancer experience is undoubtedly shaped by factors like disease stage and type, treatments received, time since diagnosis and treatment, age, and social location. But many of my participants, across categories, described bracketing some aspects of their experience while holding onto a certain degree of ontological insecurity as they redefined their lives after, with, or beyond cancer. Drawing on ontological insecurity enabled them to remain attuned to their selves: they used cancer to help them redraw boundaries in their lives and focus attention on their selves in ways they were not doing previously. While self-regulatory health practices, feminist ideologies/the women’s health movement, and environmental awareness overlap in breast cancer survivorship to produce activated patients and actualized subjectivities, my participants also discussed how the existential and medical uncertainties of their experiences led them to create new spaces for meaning in their lives. However, while many of my participants wanted to use cancer as a catalyst for self-growth or change across life domains, certainly not all of them were able to do so. Survivorship programs are critical in this regard. They can help survivors harness the uncertainty they feel instead of allowing it to become paralyzing or debilitating. Many survivors need help framing ontological insecurity as a resource to employ, not something to move beyond; but, moreover, they need spaces in which they can acknowledge these uncertainties as part of their new realities.
Advisors/Committee Members: Cerulo, Karen A (chair), Carr, Deborah (internal member), Horwitz, Allan (internal member), Almeling, Rene (outside member).
Subjects/Keywords: Breast – Cancer; Breast cancer patients; Cancer – Patients
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Hemler, Jennifer R., 1. (2015). Life with, after, or beyond cancer: breast cancer survivorship and the new normal. (Doctoral Dissertation). Rutgers University. Retrieved from https://rucore.libraries.rutgers.edu/rutgers-lib/48509/
Chicago Manual of Style (16th Edition):
Hemler, Jennifer R., 1972-. “Life with, after, or beyond cancer: breast cancer survivorship and the new normal.” 2015. Doctoral Dissertation, Rutgers University. Accessed April 21, 2021.
https://rucore.libraries.rutgers.edu/rutgers-lib/48509/.
MLA Handbook (7th Edition):
Hemler, Jennifer R., 1972-. “Life with, after, or beyond cancer: breast cancer survivorship and the new normal.” 2015. Web. 21 Apr 2021.
Vancouver:
Hemler, Jennifer R. 1. Life with, after, or beyond cancer: breast cancer survivorship and the new normal. [Internet] [Doctoral dissertation]. Rutgers University; 2015. [cited 2021 Apr 21].
Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/48509/.
Council of Science Editors:
Hemler, Jennifer R. 1. Life with, after, or beyond cancer: breast cancer survivorship and the new normal. [Doctoral Dissertation]. Rutgers University; 2015. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/48509/

University of Helsinki
22.
Gylfe, Alexandra.
New insights into the genetic basis of colorectal cancer.
Degree: Haartman Institute, Faculty of Medicine, Department of Medical Genetics; Research Programs Unit, Genome-Scale Biology Research Program, 2014, University of Helsinki
URL: http://hdl.handle.net/10138/44717
► Colorectal cancer (CRC) is the third most common cancer, and the second most common cause of cancer mortality. The aim of this thesis work was…
(more)
▼ Colorectal cancer (CRC) is the third most common cancer, and the second most common cause of cancer mortality. The aim of this thesis work was to gain novel insight into the molecular mechanisms behind CRC predisposition, as well as tumor progression and development.
Microsatellite instability (MSI) arises due to a defective mismatch repair system and is characteristic for a subset of all CRCs. Here, we aimed to identify novel MSI target genes with potential oncogenic effects. We characterized all genes overexpressed in MSI CRCs and predicted to escape nonsense-mediated decay when mutated. The mitotic checkpoint kinase TTK was identified with protein-elongating mutations in 59% of MSI CRCs. TTK has an essential role in spindle assembly checkpoint (SAC) signaling, however, the mutated protein did not show SAC weakening. While no evidence of oncogenic mechanisms was observed, the high mutation frequency of TTK argues for biological significance. In another screening effort on MSI CRCs, we sought to identify novel oncogenes with activating hotspot mutations. The exomes of 25 tumor and respective healthy colon tissues were sequenced. A total of 15 candidate oncogenes with hotspot mutations were identified. Three genes, ZBTB2, PSRC1 and RANBP2, displayed hotspot mutations also in the validation set of 86 MSI CRCs. Interestingly, the CRC-associated mutant form of ZBTB2 increased cell proliferation. Additional work is needed to further clarify the role of the identified somatic mutations in CRC tumorigenesis. The candidate oncogenes identified in this thesis work might be used to develop personalized tumor profiling and therapy.
Inherited susceptibility is estimated to be involved in approximately one-third of all CRCs. However, the great majority of inherited CRC susceptibility remains still molecularly unexplained. A recent systematic sequencing study on CRC reported a set of somatically mutated genes, termed candidate cancer (CAN) genes. We examined the mutational profiles of 15 top-ranked CAN genes for somatic mutations as well as for germline variants in 45 familial CRC cases. In our tumor set, six of the CAN genes were somatically mutated. In germline, three private missense variants were identified in CSMD3, EPHB6 and c10orf137. In another effort, we exome sequenced 96 independent cases with familial CRC. We identified 11 novel candidate CRC susceptibility genes with rare putative LoF variants. Seven loss-of-heterozygosity events, involving four genes, were observed in the data. In each occasion, the losses targeted the wild-type allele (P=0.0078), providing further support that true culprits are among the eleven genes. This study provides an interesting set of candidate predisposing genes, which might explain a subset of common familial CRC. The identified germline variants need to be validated in larger sample sets to provide firm evidence for disease predisposition. Additional work is also needed to characterize the detailed functional and clinical relevance of the identified candidate CRC predisposing genes.…
Subjects/Keywords: cancer Genetics; cancer Genetics
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Gylfe, A. (2014). New insights into the genetic basis of colorectal cancer. (Doctoral Dissertation). University of Helsinki. Retrieved from http://hdl.handle.net/10138/44717
Chicago Manual of Style (16th Edition):
Gylfe, Alexandra. “New insights into the genetic basis of colorectal cancer.” 2014. Doctoral Dissertation, University of Helsinki. Accessed April 21, 2021.
http://hdl.handle.net/10138/44717.
MLA Handbook (7th Edition):
Gylfe, Alexandra. “New insights into the genetic basis of colorectal cancer.” 2014. Web. 21 Apr 2021.
Vancouver:
Gylfe A. New insights into the genetic basis of colorectal cancer. [Internet] [Doctoral dissertation]. University of Helsinki; 2014. [cited 2021 Apr 21].
Available from: http://hdl.handle.net/10138/44717.
Council of Science Editors:
Gylfe A. New insights into the genetic basis of colorectal cancer. [Doctoral Dissertation]. University of Helsinki; 2014. Available from: http://hdl.handle.net/10138/44717

University of Helsinki
23.
Mpindi, John Patrick.
Bioinformatic tools for analysis, mining and modelling large-scale gene expression and drug testing datasets : Bioinformatic tools for analyzing large-scale biomedical datasets.
Degree: Institute of Biomedicine, Faculty of Medicine; Institute for Molecular Medicine Finland FIMM, 2016, University of Helsinki
URL: http://hdl.handle.net/10138/160326
► Bioinformatic tools applied to large-scale genomic and gene expression datasets have helped in developing our understanding of the molecular basis of cancer. They have also…
(more)
▼ Bioinformatic tools applied to large-scale genomic and gene expression datasets have helped in developing our understanding of the molecular basis of cancer. They have also become an important component of the drug discovery and development process, and potentially of personalized medicine for the future. Bioinformatic studies are now benefiting from the wealth of large datasets generated in laboratories through the use of new high-throughput technologies and their massive public repositories of data. As of October 2015,the GEO database (www.ncbi.nih.gov/geo/) alone comprised 1,597,783 samples across 15,040 platforms, and it is being updated on a daily basis. It is becoming evident that biological data are accumulating faster than the capacity of the scientific community to analyse, integrate and mine the data, as well as to create knowledge, understanding, and insights from the data. Thus, there is a growing need for better bioinformatic tools for analyzing, mining and modelling both local and global datasets.
Many data analysis projects have called for the assembly of specialized data analysis tasks and pipelines. In the future, bioinformaticians need to be involved in both methods development and in applied bioinformatics. Methods development refers to developing new algorithms, while applied bioinformatics involves putting together existing tools/pipelines in a creative way to perform an analysis task. Bioinformatics is complicated due to the heterogeneous nature of the data, varying experimental settings, small sample sizes with little replication and the existence of many distributions in the data. There is also no uniformly accepted method for large-scale integrated data analysis. The aim of this study was to develop bioinformatic and statistical tools to perform an integrated analysis of large-scale microarray gene expression, high-throughput RNAi screening and drug testing data, as well as to demonstrate the applicability of these approaches in cancer research, drug target discovery and drug testing.
First,the gene tissue index (GTI) outlier analysis method was developed to identify cancer outlier genes from large-scale microarray datasets. The need to identify genes ( outlier genes ) highly expressed in a subgroup of samples rendered some of the traditional differential expression analysis methods inadequate. The GTI method enabled the analysis and mining of outlier expression profiles from heterogeneous large-scale microarray datasets that usually contain a variable number of samples for each gene being compared. Using real and simulation study datasets, the performance of the GTI method was evaluated. We observed that the GTI performed equally well in single study settings compared to existing outlier analysis methods. Furthermore, the performance of the GTI method based on discovery studies in glioblastoma and prostate cancer was notable based on the biology of the top genes identified by the GTI. This analysis revealed many genes with outlier expression patterns, and the approach is directly…
Subjects/Keywords: cancer informatics; cancer informatics
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Mpindi, J. P. (2016). Bioinformatic tools for analysis, mining and modelling large-scale gene expression and drug testing datasets : Bioinformatic tools for analyzing large-scale biomedical datasets. (Doctoral Dissertation). University of Helsinki. Retrieved from http://hdl.handle.net/10138/160326
Chicago Manual of Style (16th Edition):
Mpindi, John Patrick. “Bioinformatic tools for analysis, mining and modelling large-scale gene expression and drug testing datasets : Bioinformatic tools for analyzing large-scale biomedical datasets.” 2016. Doctoral Dissertation, University of Helsinki. Accessed April 21, 2021.
http://hdl.handle.net/10138/160326.
MLA Handbook (7th Edition):
Mpindi, John Patrick. “Bioinformatic tools for analysis, mining and modelling large-scale gene expression and drug testing datasets : Bioinformatic tools for analyzing large-scale biomedical datasets.” 2016. Web. 21 Apr 2021.
Vancouver:
Mpindi JP. Bioinformatic tools for analysis, mining and modelling large-scale gene expression and drug testing datasets : Bioinformatic tools for analyzing large-scale biomedical datasets. [Internet] [Doctoral dissertation]. University of Helsinki; 2016. [cited 2021 Apr 21].
Available from: http://hdl.handle.net/10138/160326.
Council of Science Editors:
Mpindi JP. Bioinformatic tools for analysis, mining and modelling large-scale gene expression and drug testing datasets : Bioinformatic tools for analyzing large-scale biomedical datasets. [Doctoral Dissertation]. University of Helsinki; 2016. Available from: http://hdl.handle.net/10138/160326
24.
Karjalainen, Katja.
Candidate therapeutic targets against acute myeloid leukemia identified via screening combinatorial peptide and chemical libraries.
Degree: Department of Biosciences, Biokemia ja biotekniikka; The University of Texas - M. D. Anderson Cancer Center, Houston, Texas, USA, 2015, University of Helsinki
URL: http://hdl.handle.net/10138/154447
► Acute myeloid leukemia (AML), although rare, is highly malignant neoplasms that account for a majority of leukemia-associated deaths. AML results from an over-growth of immature…
(more)
▼ Acute myeloid leukemia (AML), although rare, is highly malignant neoplasms that account for a majority of leukemia-associated deaths. AML results from an over-growth of immature myeloid cells in the bone marrow. These cells are functionally abnormal and interfere with the production of normal hematopoietic cells. Despite apparent phenotypic uniformity, AML is a heterogeneous group of myeloid malignancies, in which multiple genetic and epigenetic aberrations accumulate in hematopoietic stem or progenitor cells leading to disturbed cellular growth, proliferation, and differentiation. The nature and number of these AML-associated molecular abnormalities can vary widely among patients. Accordingly, the survival rate also fluctuates greatly, with an average ~25% overall survival rate.
Chemotherapy is currently the mainstay treatment option for the patient with AML. However, although required to induce initial remission, chemotherapy contributes to new mutations and clonal evolution, which often leads to disease relapse. Consequently, targeted therapies are urgently needed to eradicate AML cells.
One of the major challenges in clinical oncology today is that therapeutic agents cannot be selectively delivered to tumor site without causing toxicity to rest of the body. In addition, tumor microenvironment has a key role in mediating drug efficacy and resistance, which hampers the discovery of clinically relevant drugs. Therefore, functional screening platforms that can identify cancer-specific targets as well as assess the therapeutic relevance of drug candidates within the appropriate disease microenvironment are fundamental in identification of novel targets and therapeutic agents with better attributes than conventional chemotherapy drugs.
In our studies, we have used two discovery approaches: (i) a phage display technology that allows the identification of ligands binding to physiologically relevant targets, and (ii) a novel ex vivo screening assay, which allows identification of candidate drugs against leukemia that are effective in the presence of human blood and bone marrow components.
Specifically, our studies have elucidated the function of the leukemia invadosome a supramolecular complex containing certain β2 integrins and matrix metalloproteinases in the context of extramedullary leukemia. We show that this complex is essential for extravasation of leukemia cells as well as for leukemia cell growth, and that blocking the function of this complex possesses potent anti-leukemia and anti-invasion effects.
We also demonstrate new roles for neuropilin-1 and interleukin-11 receptors in the pathogenesis of leukemia. We show that these membrane-associated proteins are highly expressed in leukemia cell lines as well as in bone marrow samples from leukemia patients. In addition, we show that the ligands binding to these receptors can be utilized in targeted drug delivery.
Finally, we developed a new functional ex vivo screening assay to identify candidate anti-leukemia agents in the presence of human blood or…
Subjects/Keywords: Cancer Biology; Cancer Biology
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Karjalainen, K. (2015). Candidate therapeutic targets against acute myeloid leukemia identified via screening combinatorial peptide and chemical libraries. (Doctoral Dissertation). University of Helsinki. Retrieved from http://hdl.handle.net/10138/154447
Chicago Manual of Style (16th Edition):
Karjalainen, Katja. “Candidate therapeutic targets against acute myeloid leukemia identified via screening combinatorial peptide and chemical libraries.” 2015. Doctoral Dissertation, University of Helsinki. Accessed April 21, 2021.
http://hdl.handle.net/10138/154447.
MLA Handbook (7th Edition):
Karjalainen, Katja. “Candidate therapeutic targets against acute myeloid leukemia identified via screening combinatorial peptide and chemical libraries.” 2015. Web. 21 Apr 2021.
Vancouver:
Karjalainen K. Candidate therapeutic targets against acute myeloid leukemia identified via screening combinatorial peptide and chemical libraries. [Internet] [Doctoral dissertation]. University of Helsinki; 2015. [cited 2021 Apr 21].
Available from: http://hdl.handle.net/10138/154447.
Council of Science Editors:
Karjalainen K. Candidate therapeutic targets against acute myeloid leukemia identified via screening combinatorial peptide and chemical libraries. [Doctoral Dissertation]. University of Helsinki; 2015. Available from: http://hdl.handle.net/10138/154447

University of Alberta
25.
Khan, Mohammad KA.
Population-based evaluation of disparities in survival of
lung cancer patients in Alberta, Canada.
Degree: MS, Department of Public Health Sciences, 2014, University of Alberta
URL: https://era.library.ualberta.ca/files/b2773x008
► Lung cancer patients of Alberta have lower relative survival compared to their counterparts in Manitoba, British Columbia and Ontario. We conducted two population-based cancer mortality…
(more)
▼ Lung cancer patients of Alberta have lower relative
survival compared to their counterparts in Manitoba, British
Columbia and Ontario. We conducted two population-based cancer
mortality studies to explore the underlying reasons. The first
study assessed disparities in mortality across five zones of
Alberta and compared them to the level of disparities between
blacks and whites in the US cancer registries. The degree of the
two disparities were similar, but more advanced stages at
diagnosis, presumably due to diagnosis delays, was partly
responsible for the disparities in the US but not in Alberta. The
second study assessed geographical disparity in mortality among
non-small-cell lung cancer patients across five zones of Alberta,
with and without taking treatment effects into consideration, and
estimated variation by oncologist. Treatment variation across zones
was observed and this variation was associated with differences in
mortality. Patient mortality varied greatly by
oncologist.
Subjects/Keywords: Cancer Epidemiology/ Cancer Biostatistics
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Khan, M. K. (2014). Population-based evaluation of disparities in survival of
lung cancer patients in Alberta, Canada. (Masters Thesis). University of Alberta. Retrieved from https://era.library.ualberta.ca/files/b2773x008
Chicago Manual of Style (16th Edition):
Khan, Mohammad KA. “Population-based evaluation of disparities in survival of
lung cancer patients in Alberta, Canada.” 2014. Masters Thesis, University of Alberta. Accessed April 21, 2021.
https://era.library.ualberta.ca/files/b2773x008.
MLA Handbook (7th Edition):
Khan, Mohammad KA. “Population-based evaluation of disparities in survival of
lung cancer patients in Alberta, Canada.” 2014. Web. 21 Apr 2021.
Vancouver:
Khan MK. Population-based evaluation of disparities in survival of
lung cancer patients in Alberta, Canada. [Internet] [Masters thesis]. University of Alberta; 2014. [cited 2021 Apr 21].
Available from: https://era.library.ualberta.ca/files/b2773x008.
Council of Science Editors:
Khan MK. Population-based evaluation of disparities in survival of
lung cancer patients in Alberta, Canada. [Masters Thesis]. University of Alberta; 2014. Available from: https://era.library.ualberta.ca/files/b2773x008

Nelson Mandela Metropolitan University
26.
Knoetze, Steyn.
The development of novel cancer targeting agents.
Degree: Faculty of Science, 2011, Nelson Mandela Metropolitan University
URL: http://hdl.handle.net/10948/d1010636
► The search for the cure for cancer is currently a multi-billion dollar industry and the search for the elusive “magic bullet”, i.e. the perfect cancer…
(more)
▼ The search for the cure for cancer is currently a multi-billion dollar industry and the search for the elusive “magic bullet”, i.e. the perfect cancer drug that would interact therapeutically with cancerous tissues while having a minimal effect on healthy cells, is the topic of many research studies in the world today. A large number of novel drugs or drug complexes and conjugates are being synthesized and subjected to rigorous evaluation in the race to find the perfect cure. ECDG (Ethylene diCysteine DeoxyGlucose) seems to have promising cancer targeting ability. Even though this compound has been described in a few publications, we could not find any reference to the current use of ECDG in oncology clinics, either as a therapeutic agent, or as a diagnostic tool for imaging purposes. It was also not possible to purchase pure ECDG anywhere in the world. This prompted us to further investigate ECDG as a possible candidate for cancer targeting research, either as an imaging agent for cancer diagnosis or complexed with an anti-cancer agent for therapeutic purposes. Detailed investigations done in our laboratory can be divided into the following categories: - Development of a synthetic method for ECDG on a multigram scale ; - Purification of prepared ECDG not using the described dialysis method that only allows the purification of small quantities of ECDG (mg scale) ; Detailed investigation of the chemistry involved in the preparation of pure ECDG and its metal complexes ; - Investigation of the stability of ECDG and its metal complexes that is essential data required for any pharmaceutical agent ; - Preparation of ECDG complexes for use as a diagnostic tool, i.e. complexation with 99mTc ; Investigation of the bio distribution of ECDG-ReO complexes ; - Preparation of an ECDG kit as a diagnostic tool for use in oncology clinics. The development of novel aromatic ligands having similar characteristics compared to ECDG, containing an N2S2 chromophore as donor atoms, to further investigate their targeting capabilities, have also been investigated. All intermediates and final compounds were characterized mainly by ESI MS, in some cases IR and NMR whenever available. Successful preparation and purification of ECDG ands its metal complexes was achieved and extensively characterized and evaluated. Efforts directed towards the development of ECDG at NECSA, South Africa, were also rewarded with significant success. Furthermore, significant development regarding the synthesis of two novel compounds with ECDG-like characteristics was also completed.
Subjects/Keywords: Cancer – Research; Cancer – Treatment
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Knoetze, S. (2011). The development of novel cancer targeting agents. (Thesis). Nelson Mandela Metropolitan University. Retrieved from http://hdl.handle.net/10948/d1010636
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Knoetze, Steyn. “The development of novel cancer targeting agents.” 2011. Thesis, Nelson Mandela Metropolitan University. Accessed April 21, 2021.
http://hdl.handle.net/10948/d1010636.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Knoetze, Steyn. “The development of novel cancer targeting agents.” 2011. Web. 21 Apr 2021.
Vancouver:
Knoetze S. The development of novel cancer targeting agents. [Internet] [Thesis]. Nelson Mandela Metropolitan University; 2011. [cited 2021 Apr 21].
Available from: http://hdl.handle.net/10948/d1010636.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Knoetze S. The development of novel cancer targeting agents. [Thesis]. Nelson Mandela Metropolitan University; 2011. Available from: http://hdl.handle.net/10948/d1010636
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Anna University
27.
Venkataraman D.
Analysis of glandular cells in Sputum cytology images for
lung Cancer detection;.
Degree: Analysis of glandular cells in Sputum cytology images
for lung Cancer detection, 2015, Anna University
URL: http://shodhganga.inflibnet.ac.in/handle/10603/39226
► One of the biggest challenges the world face today is the mortality newlinedue to Cancer One in four of all diagnosed cancers involve the lung…
(more)
▼ One of the biggest challenges the world face today
is the mortality newlinedue to Cancer One in four of all diagnosed
cancers involve the lung cancer newlinewhere the mortality rate is
high even after so much of technical and medical newlineadvances
Most lung cancer cases are diagnosed either in the third or fourth
newlinestage when the disease is not treatable The main reason for
the highest newlinemortality due to lung cancer is because of non
availability of prescreening newlinesystem which can analyze the
cancer cells at early stages So it is necessary to newlinedevelop a
prescreening system which helps doctors to find and detect lung
newlinecancer at early stages newlineOut of all various types of
lung cancers adenocarcinoma is newlineincreasing at an alarming
rate The reason is mainly attributed to the increased newlinerate
of smoking both active and passive So it is necessary to screen
newlineadenocarcinoma cancer newlineVarious modalities like light
microscopy X ray CT and MRI are newlineused for the detection and
diagnosis of lung cancer Each of these has its own
newlineadvantages and disadvantages This work is to develop a low
cost and newlineeffective pre screening system which can be
deployed on a wide scale newlineSeveral previous studies suggest
that sputum cytology is the best and newlineaffordable method for
lung cancer detection newline newline
reference p161-171.
Advisors/Committee Members: Suganthi J.
Subjects/Keywords: Adenocarcinoma cancer; Cancer detection
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
D, V. (2015). Analysis of glandular cells in Sputum cytology images for
lung Cancer detection;. (Thesis). Anna University. Retrieved from http://shodhganga.inflibnet.ac.in/handle/10603/39226
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
D, Venkataraman. “Analysis of glandular cells in Sputum cytology images for
lung Cancer detection;.” 2015. Thesis, Anna University. Accessed April 21, 2021.
http://shodhganga.inflibnet.ac.in/handle/10603/39226.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
D, Venkataraman. “Analysis of glandular cells in Sputum cytology images for
lung Cancer detection;.” 2015. Web. 21 Apr 2021.
Vancouver:
D V. Analysis of glandular cells in Sputum cytology images for
lung Cancer detection;. [Internet] [Thesis]. Anna University; 2015. [cited 2021 Apr 21].
Available from: http://shodhganga.inflibnet.ac.in/handle/10603/39226.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
D V. Analysis of glandular cells in Sputum cytology images for
lung Cancer detection;. [Thesis]. Anna University; 2015. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/39226
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

McMaster University
28.
Hu, Jiarui.
Method to estimate cancer overdiagnosis with prostate screening.
Degree: MSc, 2018, McMaster University
URL: http://hdl.handle.net/11375/23969
► Aim: Several studies have tried to quantify overdiagnosis of prostate cancer with Prostate-specific antigen(PSA) screening, but estimates vary widely. This study aims to evaluate the…
(more)
▼ Aim: Several studies have tried to quantify overdiagnosis of prostate cancer with Prostate-specific antigen(PSA) screening, but estimates vary widely. This study aims to evaluate the degree of overdiagnosis of prostate cancer with 10 or 14 follow-up years after the stop of screening in Finland.
Methods: We selected 80379 men aged 55-69 years who were randomized to a screening or a control arm, distinguishing four birth cohorts: 1941-44,1937-40, 1933-36 and 1929-32. The first PSA screening test occurred during1996-1999. Men without detected as prostate cancer in the previous screening would be invited to the next screening 4 years later. The estimate of overdiagnosis is the ratio of the cumulative excess incidence to the cumulative incidence of prostate cancer in the screened group after the year-specific incidence became stable.
Results: The patterns of all incidences in these four cohorts have not become stable yet, and the difference of cumulative incidence in the current longest follow- up years is the best estimate of overdiagnosis so far.
Conclusion: Overdiagnosis rates of prostate cancer in people who received screening in Finland was estimated as 2.27%,15.4%, 11.4%, and 10.2% for 1929-32, 1933-36,1937-40, and 1941-44 cohorts, respectively.
Thesis
Master of Science (MSc)
Advisors/Committee Members: Walter, Stephen, Mathematics and Statistics.
Subjects/Keywords: cancer overdiagnosis; prostate cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Hu, J. (2018). Method to estimate cancer overdiagnosis with prostate screening. (Masters Thesis). McMaster University. Retrieved from http://hdl.handle.net/11375/23969
Chicago Manual of Style (16th Edition):
Hu, Jiarui. “Method to estimate cancer overdiagnosis with prostate screening.” 2018. Masters Thesis, McMaster University. Accessed April 21, 2021.
http://hdl.handle.net/11375/23969.
MLA Handbook (7th Edition):
Hu, Jiarui. “Method to estimate cancer overdiagnosis with prostate screening.” 2018. Web. 21 Apr 2021.
Vancouver:
Hu J. Method to estimate cancer overdiagnosis with prostate screening. [Internet] [Masters thesis]. McMaster University; 2018. [cited 2021 Apr 21].
Available from: http://hdl.handle.net/11375/23969.
Council of Science Editors:
Hu J. Method to estimate cancer overdiagnosis with prostate screening. [Masters Thesis]. McMaster University; 2018. Available from: http://hdl.handle.net/11375/23969

Addis Ababa University
29.
Atsednesh, Getachew.
Psychosocial Impact of Childhood Cancer on Parents with Children Diagnosed with Cancer: The Case of Parents Receiving Service at Tikur Anbessa Specialized Hospital
.
Degree: 2014, Addis Ababa University
URL: http://etd.aau.edu.et/dspace/handle/123456789/5483
► Cancer, one of the non-communicable diseases is gaining momentum in Ethiopia. As the country has only one cancer treatment center for both adults and children,…
(more)
▼ Cancer, one of the non-communicable diseases is gaining momentum in Ethiopia. As
the country has only one
cancer treatment center for both adults and children, the
challenges associated with that are immense. In line with that, this study, focused on
identifying the psychosocial impacts parents of children diagnosed with
cancer have
and how they cope with those impacts. Qualitative approach particularly case study
design was used in this study. The tools for primary data collection were in-depth
interviews and focus group discussions in order to gain in-depth information.
Purposive sampling technique was used to select participants leading to sixteen
parents of children with
cancer who are currently following either admitted or as an
outpatient to be involved in the study. In addition to that, three health care
professionals were involved as key informants. The findings of the study reveal that
parents with children diagnosed with
cancer had encountered different psychological,
social and physical impacts that are interdependent on one another. In addition to that,
parents use different problem and emotional focused coping strategies to mitigate the
challenges they encounter. Different informal and formal support systems also assist
them to cope. However, the findings also show that the support parents are receiving
is more inclined towards social support neglecting the psychological problems they
have. The findings of the study present social work implication in the areas of
practice, education, research and policy.
Advisors/Committee Members: Ashenafi Hagos (PhD.) (advisor).
Subjects/Keywords: Childhood Cancer;
Cancer Treatment
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Atsednesh, G. (2014). Psychosocial Impact of Childhood Cancer on Parents with Children Diagnosed with Cancer: The Case of Parents Receiving Service at Tikur Anbessa Specialized Hospital
. (Thesis). Addis Ababa University. Retrieved from http://etd.aau.edu.et/dspace/handle/123456789/5483
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Atsednesh, Getachew. “Psychosocial Impact of Childhood Cancer on Parents with Children Diagnosed with Cancer: The Case of Parents Receiving Service at Tikur Anbessa Specialized Hospital
.” 2014. Thesis, Addis Ababa University. Accessed April 21, 2021.
http://etd.aau.edu.et/dspace/handle/123456789/5483.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Atsednesh, Getachew. “Psychosocial Impact of Childhood Cancer on Parents with Children Diagnosed with Cancer: The Case of Parents Receiving Service at Tikur Anbessa Specialized Hospital
.” 2014. Web. 21 Apr 2021.
Vancouver:
Atsednesh G. Psychosocial Impact of Childhood Cancer on Parents with Children Diagnosed with Cancer: The Case of Parents Receiving Service at Tikur Anbessa Specialized Hospital
. [Internet] [Thesis]. Addis Ababa University; 2014. [cited 2021 Apr 21].
Available from: http://etd.aau.edu.et/dspace/handle/123456789/5483.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Atsednesh G. Psychosocial Impact of Childhood Cancer on Parents with Children Diagnosed with Cancer: The Case of Parents Receiving Service at Tikur Anbessa Specialized Hospital
. [Thesis]. Addis Ababa University; 2014. Available from: http://etd.aau.edu.et/dspace/handle/123456789/5483
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
30.
Lopez Almeida, Leonor.
Rôle de Lano/LRRC1 dans le cancer du sein et influence sur les cellules souches cancéreuses : Role of Lano/LRRC1 in breast cancer and influence in cancer stem cells.
Degree: Docteur es, Pathologie humaine. Oncologie, 2017, Aix Marseille Université
URL: http://www.theses.fr/2017AIXM0653
► Les chiffres mondiaux estiment l’incidence du cancer du sein, cancer féminin le plus fréquent, à 1.3 millions de cas par an, dont près d’un tiers…
(more)
▼ Les chiffres mondiaux estiment l’incidence du cancer du sein, cancer féminin le plus fréquent, à 1.3 millions de cas par an, dont près d’un tiers a une issue fatale.La polarité est indispensable à l’organisation cellulaire, ses défauts peuvent mener au cancer. Notre projet est focalisé sur une protéine de la polarité, Lano, et son influence sur le cancer du sein et les CSC. L’Institut Paoli-Calmettes dispose d’environ 10000 échantillons de cancer du sein dont l’analyse montre que la perte de Lano est corrélée à des cancers du sein plus graves et à une augmentation des CSC. Nos résultats in vitro, sur des cellules de cancer du sein humain et in vivo montrent aussi que Lano est un régulateur du nombre de CSC. Les CSC sont une ces causes principales de rechute des patients. La suite de nos travaux pourrait déterminer si Lano est un facteur pronostique de la maladie ou une cible thérapeutique possible.
Breast cancer is the most common cancer in women. Worldwide figures estimate the incidence of breast cancer at 1.3 million cases per year, nearly one third of them has a fatal outcome.Our project focuses on the study of Lano, a polarity protein, in breast cancer and stem cells. The hospital “Institute Paoli-Calmettes” gathered 10,000 breast cancer samples whose analysis shows that the loss of Lano has a role in breast cancer and stem cells. Our in vitro results on human breast cancer cells and in vivo also show that Lano is a regulator of the number of cancer stem cells. Cancer stem cells are one of the major causes of relapse in patients. The rest of our work could determine if Lano could be a prognostic factor of the disease or a possible therapeutic target.
Advisors/Committee Members: Santoni, Marie-Josée (thesis director).
Subjects/Keywords: Cancer du sein; Breast cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Lopez Almeida, L. (2017). Rôle de Lano/LRRC1 dans le cancer du sein et influence sur les cellules souches cancéreuses : Role of Lano/LRRC1 in breast cancer and influence in cancer stem cells. (Doctoral Dissertation). Aix Marseille Université. Retrieved from http://www.theses.fr/2017AIXM0653
Chicago Manual of Style (16th Edition):
Lopez Almeida, Leonor. “Rôle de Lano/LRRC1 dans le cancer du sein et influence sur les cellules souches cancéreuses : Role of Lano/LRRC1 in breast cancer and influence in cancer stem cells.” 2017. Doctoral Dissertation, Aix Marseille Université. Accessed April 21, 2021.
http://www.theses.fr/2017AIXM0653.
MLA Handbook (7th Edition):
Lopez Almeida, Leonor. “Rôle de Lano/LRRC1 dans le cancer du sein et influence sur les cellules souches cancéreuses : Role of Lano/LRRC1 in breast cancer and influence in cancer stem cells.” 2017. Web. 21 Apr 2021.
Vancouver:
Lopez Almeida L. Rôle de Lano/LRRC1 dans le cancer du sein et influence sur les cellules souches cancéreuses : Role of Lano/LRRC1 in breast cancer and influence in cancer stem cells. [Internet] [Doctoral dissertation]. Aix Marseille Université 2017. [cited 2021 Apr 21].
Available from: http://www.theses.fr/2017AIXM0653.
Council of Science Editors:
Lopez Almeida L. Rôle de Lano/LRRC1 dans le cancer du sein et influence sur les cellules souches cancéreuses : Role of Lano/LRRC1 in breast cancer and influence in cancer stem cells. [Doctoral Dissertation]. Aix Marseille Université 2017. Available from: http://www.theses.fr/2017AIXM0653
◁ [1] [2] [3] [4] [5] … [1051] ▶
.